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Abstract
Wang, Ting, Ph.D., Fall 2014

Cell and molecular Biology

P115‐SNARE interactions reveal a new model of function for the tethering factor
p115.
Chairperson: Jesse Hay
The endomembrane system consists of several connected yet distinct
compartments, constantly exchanging material via the flow of membrane‐enclosed
vesicles. Protein transport between the endoplasmic reticulum (ER) and the Golgi is
one of the most fundamental trafficking pathways in eukaryotic cells, as well as the
first step in the secretory pathway. The fusion between vesicles and target
membranes requires the orchestration of tethers, Rabs, SM proteins and SNAREs.
Tethering factors regulate the targeting of membrane‐enclosed vesicles and
enhance the efficiency as well as specificity of membrane fusion. P115, a Golgin
family tether, has been shown to participate in multiple stages of ER/Golgi
transport. Despite extensive study, p115’s mechanism of action is poorly
understood. SNARE proteins make up the machinery for membrane fusion, and
strong evidence shows that p115’s function is directly linked to its interaction with
SNAREs. Using a gel filtration binding assay, we have demonstrated that in solution
p115 stably interacts with ER/Golgi SNAREs rbet1 and sec22b, but not membrin
and syntaxin 5. These binding preferences stemmed from selectivity of p115 for
monomeric SNARE motifs as opposed to SNARE oligomers. Soluble monomeric
rbet1 can compete off p115 from COPII vesicles. Furthermore, excess p115 inhibits
p115 function in trafficking. We conclude that monomeric SNAREs are a major
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binding site for p115 on COPII vesicles, and that p115 dissociates from its SNARE
partners upon SNARE assembly. Our results suggest a model in which p115 forms a
mixed p115/SNARE helix bundle with a monomeric SNARE, facilitates the binding
activity and/or concentration of the SNARE at pre‐fusion sites, and is subsequently
ejected as SNARE complex formation and fusion proceed.
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Chapter I: Introduction
A. The Secretory Pathway Overview
The eukaryotic secretory pathway provides the foundation for many cellular
processes. The endomembrane system consists of several connected yet distinct
compartments, constantly exchanging material via the flow of membrane‐enclosed
vesicles. Proteins and other essential molecules are transported to their
destinations throughout the cell by these vesicles. Vesicles containing sorted cargo
are generated by one compartment, attached to microtubules, and moved to another
compartment. Upon arrival, vesicle membranes fuse with the membranes of the
target compartment, and the content of vesicles are released into the organelle
lumen. The sorting of cargo, budding of vesicles, and the eventual membrane fusion
comprise a sequence of tightly regulated and highly specific individual steps that are
carried out through the orchestration of different families of proteins [1].
The endoplasmic reticulum is considered the ‘gate’ to the secretory pathway.
ER is the entry point for newly synthesized proteins, directed by an ER signal
sequence [2]. After being sorted in the ER, proteins are moved in COPII coated
vesicles to the Golgi apparatus, where they receive further modification and are
either retained, cycled back to the ER, or transported to other parts of the cell. The
Golgi therefore provides an important connecting point for other branches of the
secretory pathway, including the exo‐ and endocytosis [Figure 1].
Anterograde transport from ER to Golgi consists of the flow of COPII‐coated
vesicles [1, 3]. Sculpted from ER membrane, these spherical vesicles undergo
homotypic fusion and give rise to an intermediate compartment between the ER and
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Golgi, termed versicular tubular cluster (VTC). VTCs then move along microtubules
towards the Golgi, during which process anterograde cargoes are further
concentrated as ER‐localized proteins, export machinery, and excess membrane are
returned to the ER.

B. Key Components of the Secretory Pathway
a. Coat proteins
Coat proteins are important components involved in cargo recruitment and
membrane remodeling during the budding of vesicles. Coatomers assemble into
cage‐like structures on a specific membrane patch, bending the membrane and
eventually 'sculpt out' spherical vesicles from the donor membrane. There are three
major groups of coatomers: COPI, COPII, and Clathrin [4]. In general, coatomer cages
are assembled by proteins containing the α‐solenoid domain and the β‐propeller
domain, even though the detailed architecture of the cages are distinct [5]. The COPI
coat consists of 7 subunits (α, β, β′, ε, γ, δ, and ζ), and the coated vesicles carry out
retrograde ER‐Golgi transport as well as intra‐Golgi transport [6]. The COPII coat is
assembled by Sec13, Sec31, Sec23, and Sec24 at the ER exit site, and COPII‐coated
vesicles mediate anterograde ER‐Golgi transport [7, 8]. The Clathrin coat, assembled
by clathrin heavy chains (CHCs) and clathrin light chains (CLCs), has been
implicated to play a part in multiple trafficking pathways, including endocytosis and
protein sorting in the trans‐Golgi network [9, 10, 11]. The assembly of coats is
typically regulated by membrane‐anchored GTP‐binding proteins (e. g. Sar1 for
COPII, Arf1 and ‐3 for COPI and Clathrin) [11].
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b. SNARE proteins
A group of proteins termed soluble N‐ethylmaleimide‐sensitive fusion
protein (NSF) attachment protein receptors (SNAREs) play an especially important
role in vesicle trafficking. SNAREs are responsible for catalyzing the merger of
membranes. The assembly of SNARE complexes overcomes the energy barrier and
directly brings the opposing membranes together, which leads to fusion. SNAREs
are characterized by a homologous domain called the SNARE motif, which spans
approximately 60~70 residues [12]. The monomeric SNARE motif is usually
unstructured, yet it adopts an α‐helical conformation when it enters into a SNARE
complex [12, 13]. For most SNARE proteins, the SNARE motif is sandwiched
between an N‐terminal domain and a C‐terminal transmembrane domain (or other
type of membrane‐anchor, such as palmitoylation or prenylation) [12].
The formation of the SNARE complex involves the SNARE motifs of four
cognate SNARE proteins. The assembly of SNARE complexes starts from the N‐
termini of the SNARE motifs, and proceeds through the lengths of the domains in a
‘zipping up’ motion [14]. Through the SNAREs’ C‐terminal membrane anchors, the
assembly of the four‐helix bundle pulls the opposing membranes close together,
dehydrating the apposed membrane bilayers, initiating lipid mixing between
membranes as well as the formation of a fusion pore, the expansion of which
ultimately results in bilayer fusion [14, 15, 16]. The eventual product of SNARE
assembly is an ultra‐stable complex consisting of four parallel‐aligned α‐helices,
sustained by multiple‐layer hydrophobic interactions [17]. A single polar layer,
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termed the 0 layer, exists in the central region of the four‐helix bundle. One of the
SNARE motifs contributes an arginine (R) residue to the layer, which engages in
hydrogen bonds with three glutamine (Q) residues contributed by the other three
SNARE motifs. SNARE proteins can thus be classified into R‐ and Q‐ SNAREs. Based
on their positions in the SNARE complex, Q‐SNAREs can be further grouped into Qa,
Qb, and Qc subtypes [18].
Utilizing energy from ATP hydrolysis, the SNARE complex can be
disassembled by the chaperone NSF and its co‐factor α‐SNAP [19, 20]. The recycled
SNAREs can participate in further membrane fusion events [Figure 2].
Sec1/Munc18‐like (SM) proteins are a group of proteins that facilitate
SNAREs in fusion. The typical structure of SM protein resembles a U‐shaped 'clasp'
[21, 22], and appears to function as a clasp for the four‐helix bundle SNARE complex
[22]. SM proteins bind the 'closed' four‐helix conformation of syntaxins as well [21],
but they also contain an additional binding site for a N‐terminal peptide of the
syntaxin Habc domain [21, 23]. This interaction possibly anchors the SM protein to
the SNARE complex, leaving the 'U' part of SM protein free to interact transiently
with and stabilize the forming four‐helix bundle [22].
These interactions suggest a regulatory role for SM proteins in SNARE
complex assembly or/and disassembly [22]. Due to their multiple binding sites on
SNAREs, the exact functions of SM proteins are not clear. There is also evidence
suggesting that SM proteins can 'proofread' SNAREs [24, 25], by disassembling the
wrongly‐paired SNAREs and stabilizing cognate SNARE complexes [24].
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Another important feature of SNARE proteins is the N‐terminal domain.
Unlike the homologous SNARE motif, despite some sequence or/and structural
homology shared between certain groups of SNAREs (i. e. the syntaxin family [26,
27]), the structure and function of the N‐terminal domain varies among SNAREs.
Three‐helix bundle is a very common conformation, and the ER‐Golgi SNARE
membrin has this type of N‐terminal domain. The N‐terminal domains of syntaxins
also adopt an antiparallel three‐helix bundle conformation [28], and are termed Habc
domains. These domains possess affinities for their respective SNARE motifs, and
the intramolecular interactions appear to regulate the activity of the syntaxin
SNARE motif. The removal of syntaxin 5 N‐terminal domain greatly enhances the
incorporation of syntaxin 5 into SNARE complexes [29]. Similar effects have been
observed for other syntaxins [30, 31], suggesting the N‐terminal domain as a
potential negative regulator for syntaxin SNARE activities.
Profilin‐like folds are found among the N‐terminal domains of exocytotic
SNARE VAMP7, mammalian neuronal SNARE ykt6, and ER‐Golgi SNARE sec22b [32,
33, 34]. Termed longin domains, their functions are not very well understood. It has
been reported that the longin domains of VAMP7 and ykt6 negatively regulate their
SNARE activities, in the same manner as a syntaxin’s N‐terminal domain [35]. There
is also evidence suggesting that the two longin domains are important for the
localization of their respective SNAREs [34‐38]. Such specific regulatory or targeting
effects, however, have not been observed with sec22b, although the longin domain
of sec22b seems to affect the SNARE’s ER export [36‐38]. The longin domain has
also been established as a potential coat‐recruitment site [39].

5

c. Vesicle tethering and tethers
Other key components of the secretory pathway include tether proteins. It
has been known since 1998 that SNAREs are required and sufficient for catalyzing
the fusion of liposomes [40]. However, the rate of SNARE‐only fusion is drastically
lower than that of fusion that occurs under physiological conditions. This suggests
potential cofactors participating in fusion or its upstream events.
The targeting and tethering of vesicles prior to their fusion greatly enhance
fusion’s efficiency [41, 42]. Furthermore, although only cognate SNAREs assemble
complex efficiently, and in vitro SNARE‐mediated liposome fusion has been shown
to be highly specific [43, 44], evidence suggests that fusion can be carried out by
non‐cognate SNAREs as well [45]. Thus, tethering of vesicles confers another degree
of specificity to SNARE‐mediated fusion. A number of protein factors required for
tethering have been identified and characterized, and can be roughly classified into
two groups: Proteins that act as an individual rod‐like tethers, and proteins that
function as a stable part of a multi‐component tethering complex.
It was believed that vesicles shed their coats soon after budding, which
suggests that coatomers are unlikely to be involved in vesicle tethering and fusion
[46]. However, more recent studies have shown that sections of the coat can stay on
the vesicles until tethering [47], and coat proteins serve as a potential binding site
for tether recruitment. Sec23, a COPII subunit, binds directly to Bet3, one of the core
subunits shared between all three transport protein particle (TRAPP) complexes
[47, 48], whereas COPI subunit γ‐COP interacts with two of TRAPPII‐specific
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subunits [49]. COPI subunits also interact with the conserved oligomeric Golgi
(COG) complex [49], as well as Dsl1 [49].
In addition to coatomers, Rabs and SNAREs also play a part in tether
recruitment and localization. Most tethers are Rab effectors (more in the Rab
GTPases section). Rab1 recruits tether p115/Uso1p to the COPII vesicles [50],
whereas Sec4p directs subunits of the tethering complex exocyst to post‐Golgi
vesicles [51]. P115's population on COPII vesicles is also affected by SNARE status
[52].
First identified as autoantigens, the rod‐like tethers include the well‐
characterized endosomal tether EEA1, as well as the Golgin protein family. The
members of this group often form homodimers and are characterized by
structurally predominant elongated α‐helical coiled‐coil domains [53]. Golgins and
other rod‐like tethers are usually conserved across species, with central helical
region and non‐helical termini [53, 54]. P115/Uso1p, GM130, and Giantin are some
other examples of this group.
Golgins are primarily localized to the Golgi, and their role in maintaining the
homeostatsis of Golgi has been extensively studied [55‐60]. The exact molecular
detail of function for these rod‐like tethers, however, is not very well understood.
Due to their elongated shape, a ‘vesicles on the strings’ model was proposed [55,
Figure 3]. In this model, Golgins assemble into a fibrous matrix (‘strings’) protruding
from the surface of Golgi cisternae, the distal ends of which attach to vesicles such
that vesicles may be passed between different ‘strings’. This would allow vesicles to
be transported between the succesive Golgi stacks without diffusing away.
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Extensive coordination between Golgins has been reported, suggesting transport
mediated by these proteins is a concerted effort [59, 60].
Several rod‐like tethers, in particular p115/Uso1p, are not restricted to the
Golgi and have a more general role in the secretory pathway. Similar to their
hypothetical model of action at the Golgi, in other steps of the secretory pathway,
coiled‐coil tethers are proposed to form elongated structures and to capture vesicles
prior to the docking of SNAREs, and possibly to facilitate the downstream events by
catalyzing the assembly of SNARE complexes [49, 62]. Despite their structural
similarities, tethers localize to their respective compartments and are specific for
each step in the secretory pathway, thus enhancing the overall specificity of vesicle
targeting and the membrane fusion system [63] [Figure 4 and Table 1].
On the other hand, a considerable number of tethering factors form
multisubunit tethering complexes (MTCs). Usually conserved in yeast and mammals,
these complexes contain 3‐10 subunits. In most cases, subunits within a tethering
complex share a certain level of sequence or structural similarity [64]. Similar to
rod‐like tethers, tethering complexes are found to participate at every branch of the
secretory pathway [64, 65]. Based on sequence homology, the COG, Dsl1, exocyst,
and GARP (Golgi‐associated retrograde protein) complexes have been collectively
given the name complex associated with tethering containing helical rods (CATCHR)
family. Structural analysis indicates that many subunits of these MTCs are
evolutionarily related [64]. The Non‐CATCHR group of MTCs includes the TRAPPs,
HOPS (homotypic fusion and protein sorting) complex, and CORVET (class C core
vacuole/endosome tethering) complex. Some major and well‐studied ER‐Golgi
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complexes include: TRAPPI, II and III, which are proposed to function in concert
with p115/Uso1p, at the late stage of ER‐Golgi transport; the COG complex, which
primarily functions within the Golgi apparatus [66]; exocyst, which primarily
localizes to the trans‐Golgi network and participates in the trafficking of post‐Golgi
vesicles to the plasma membrane [67, 68]; and the COPI vesicle tether Dsl1, whose
structure and function has been relatively well characterized [69, 70].

d. Rab GTPases
Rab GTPases also play an important part in membrane transport. As
molecular ‘switches’, Rabs regulate many trafficking processes including cargo
recruitment, coat assembly and disassembly, vesicle movement, as well as
membrane fusion [71]. In addition, Rabs provide enhanced membrane identity, as
exemplified by their role in the specific recruitment of tethering factors [72, 73].
All the aforementioned tethers or tethering complexes, with the exception of
Dsl1 and TRAPPs (which are Rab GEFs), are/contain Rab effectors [74]. P115 and
GM130 are effectors of Rab1/Ypt1, which has been shown to play a key role in ER‐
Golgi transport. Giantin, on the other hand, interacts with both Rab1 and Rab6,
suggesting an additional regulatory role for this Golgin [75]. The COG tethering
complex is the effector of several Golgi Rabs, possibly because COG acts as a central
point for multiple retrograde tethering events at Golgi [76]. In addition, Sec4
recruits the exocyst [51], Ypt6/Rab6 binds GARP [77, 78], and HOPS interacts with
Ypt7/Rab7, whereas the related CORVET binds the Rab Vps21 [79‐81]. Rabs appear
to regulate the tethering process by coordinating between various families of
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players, such as SM proteins, tethers, and SNAREs [71]. The lack of an identified
Dsl1 Rab possibly hints at a different regulatory mechanism for Dsl1 [74].
Recently, the exact role of TRAPP complexes in membrane tethering has been
called to question. TRAPPs do not share structural or sequence homology with the
CATCHR family, nor the HOPS and CORVET complexes [64]. All MTCs with the
exception of Dsl1 are Rab effectors, whereas TRAPPs are Rab GEFs [82]. Evidence
suggests that TRAPPs are required for the tethering process [83], yet it is unknown
whether TRAPP is capable of binding receptors on both vesicle and target
membranes simultaneously [82]. Therefore, it is unclear whether TRAPPs act by
directly tethering apposed membranes, or by regulating other tethers' functions
through interactions with Rab1.

C. SNARETether Interactions
As upstream regulators and fusion cofactors, almost all known tethers or MTCs
can interact with at least one SNARE [62]. P115, as a more ‘general’ tethering factor,
interacts with various ER‐Golgi SNAREs (see P115‐SNARE interactions below).
Other coiled‐coil tethers and MTCs also have SNARE binding properties.
It has been shown that interactions between tethers and SNAREs can regulate
SNARE activities. GM130’s binding to sytnaxin 5 seems to inhibit its incorporation
into binary SNARE complex [84]. Sec6, a subunit of the exocyst, interacts with the
yeast plasma membrane sec9 [85], and regulates sso1‐sec9 binary complex
assembly [86]. Cog4, a COG subunit, also interacts with syntaxin 5 and facilitates its
SNARE assembly [87]. The endosomal tether EEA1 interacts with trans‐Golgi SNARE
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syntaxin 6 and endosomal syntaxin 13 [88, 89], and these interactions seem to be
required for endosome fusion [90].
Tethers can also regulate the localization of SNARE proteins. Interactions
between COG component Cog6 and syntaxin 6 seem to affect syntaxin 6’s
localization to trans‐Golgi [91]. In fact, the COG complex seems to be important for
the localization of many Golgi SNAREs [92].
The physiological implications of many tether‐SNARE interactions are not
entirely clear. However, due to the fact that many tethers or MTCs interact with
multiple SNAREs, it is possible that they facilitate SNARE complex assembly by
bringing SNAREs together [62]. As for the SNARE motif‐binding tethers, it is
possible that they function in concert with SM proteins and proofread/stabilize
SNARE complexes [94].

D. Research Rationale
a. Tether protein p115
One of the better‐studied Golgins, p115, was first identified as a high
molecular weight factor required for the docking/tethering step in intra‐Golgi
vesicular transport and transcytosis [56, 94, 95]. Its yeast homolog, Uso1p, was also
required for ER‐Golgi transport [94]. These early studies placed p115/Uso1p’s
action prior to SNARE‐mediated membrane fusion [96‐99], although later evidence
also suggests a downstream role for p115/Uso1p [50, 100].
P115, as a Golgin, exists as a homodimer in the cell [56, 101, 102]. It is
localized primarily to the cis‐face of the Golgi, but has an abundant cytosolic pool as
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well [103]. The bovine p115 monomer consists of a globular head domain, which
spans residues 1‐651, an elongated coiled‐coil domain (residues 652‐909), and an
acidic tail domain (residues 910‐961) [101]. Based on primary sequence
comparison, the head domain of p115 contains two highly conserved regions, H1
and H2 [101, 104]. Recent X‐ray crystallography studies revealed that the
dimerization interface is also located within the head domain, overlapping with H2,
whereas the Rab1 binding site was located to the H1 region [104, 105]. In addition,
binding sites for the COPI component beta‐COP as well as COG2 of the COG complex
was also mapped to the head region [104, 105]. Overall, the head region of p115
consists of multi‐helical armadillo repeat arranged in right‐handed superhelix
conformation [105].
Following the head domain, the coiled‐coil domain of bovine p115 consists of
four separate predicted coiled‐coils (CC1‐CC4), which cover residues 652‐694, 732‐
766, 786‐820, and 849‐897, respectively [101]. The proline and glycine rich
interruptions between the coiled‐coils are predicted to function as flexible hinges,
possibly allowing the normally elongated p115 molecule to adopt a bent
conformation during its functional cycle [101, 102]. Multiple bent conformations
have been observed for p115 by cryo‐EM [102]. It was proposed that CC1 may
contain an alternative Rab1 binding site that is only exposed upon the binding of
other Golgi tethers [106], however, the functional significance of this cryptic site
remains unclear. Following the coiled‐coil domain is a region of high acidic amino
acid content; the extreme C‐terminus of p115 forms a very hydrophilic, acidic tail
[101]. Other members of the Golgin family, such as GM130 and Giantin, can interact
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with this part of the molecule [107‐111], though the functional significance of these
interactions is controversial [112‐114]. [Figure 5]
Various binding partners have been identified for p115. Similar to other
Golgins, p115 is a direct effector of Rab GTPase, and seems to be recruited to COPII
vesicles through interactions with Rab1 and possibly SNAREs [50, 52]. It has been
reported that Rab30 in Drosophila is another potential Rab for p115 [115]. SNAREs
that interact with p115 include ER‐Golgi SNAREs sec22b, syntaxin 5, membrin and
rbet1, as well as Golgi SNAREs Gos28 and GS15, and the neuronal Ykt6 [116]. A SM
protein Sly1 also interacts with p115's SNARE‐binding domain [116], although the
significance of this interaction is unclear.
P115 engages in extensive interactions with many Golgi tethers, among
which are Giantin and GM130, two other Golgins. Interactions between p115,
GM130 and Giantin appear to be important for maintaining the integrity of Golgi
[108, 111], although contradictory evidence has also been reported [113, 114].
Cog2, a COG subunit, is another p115 binding partner. P115 interacts with GBF1, an
ADP ribosylation factor (ARF) GEF [117], possibly providing a link between Rab1
and GBF1, which plays a part in the recruitment of COPI coat [118]. A subset of these
interactions are depicted in Figure 4A. P115 also directly interacts with the COPI
subunit β‐COP, which is consistent with p115's role in retrograde ER‐Golgi
transport and intra‐Golgi transport [105]. P115 has multiple phosphorylation sites,
and is regulated by a casein kinase II type enzyme during mitosis [109].
P115 is required for a variety of trafficking processes in the cell. The absence
of Uso1p/p115 impairs the docking of COPII vesicles [98], as well as the general
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early stages of ER‐Golgi transport [99]. Depletion of p115 also causes vacuole
fragmentation in yeast [94], slows down the stacking of Golgi [56, 57], and disrupts
Golgi integrity [119]. In addition to being a Rab1 effector, p115 can affect the
recruitment of Rab1 as well [120]. Cleavage of p115 inhibits exocytosis [112]. Also,
p115 may regulate Golgi dynamics during mitosis [57]. Taken together with the
ubiquitous distribution of p115, these evidences suggest that p115 functions at
multiple steps of the early secretory pathway.
Studies of the p115 requirement in the intact animal have also been carried
out. P115 knockout (KO) results in embryonic lethality in both mice and Drosophila
[114, 121]. Cells from the KO embryos display the characteristic dispersed Golgi
morphology seen with p115 knockdown in cultured mammalian cells, suggesting a
role of p115 in early embryonic development. Conditional knockout of p115/Uso1p
in the C. elegans intestine caused accumulation of transmembrane receptor RME2 in
the ER of oocytes, suggesting a block in RME2 transport. In intact animals, p115
depletion seems to affect the trafficking of membrane proteins more than that of
soluble proteins [114]. Similar patterns were observed with cultured mammalian
cells as well [114, 119, 122]. P115's role in protein sorting at ER exit sites may
explain this difference. It was shown that the incorporation of GPI‐anchored
proteins into ER‐derived vesicles requires Uso1p/p115 function [123], thus p115
could have a selective effect on the sorting of certain cargos.

b. P115SNARE interactions
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In early yeast studies, p115 has been implicated to function upstream of
SNAREs. Possible interactions between p115 and SNAREs were demonstrated when
the lack of p115/Uso1p caused a decrease in the amount of SNARE complexes
formed in yeast [96]. There is also evidence suggesting that p115’s function is
dependent upon its interactions with specific SNAREs [113]. The overexpression of
Bet1p or Sec22p, two yeast ER‐Golgi SNAREs, suppresses the USO1 deletion in yeast
[96]. Later studies identified a group of ER‐Golgi SNAREs that potentially interact
with p115. When coupled to Neutravidin beads, both CC1 and CC4 were able to
retain a subset of ER‐Golgi SNAREs (membrin, rSec22p, Bet1p), as well as Golgi
SNAREs Ykt6p and GOS‐28, from rat liver Golgi extract [116].
In vivo functional replacement of p115 has revealed that the presence of CC1,
one of the SNARE‐binding domains, is required for maintaining the structure of the
Golgi, as expression of CC1‐deleted p115 construct failed to rescue the fragmented
Golgi phenotype observed with endogenous p115 depletion. Other smaller
modifications of CC1 domain also reduced the construct's ability to restore the Golgi
ribbons [113]. The same assay also confirmed CC1’s requirement for VSV‐G
transport to cell surface. Taken together, these data imply that CC1‐SNARE
interactions are indispensable for the function of p115.
In previous co‐immunoprecipitation experiments, the CC4 domain, despite
its homology to the SNARE motif, appears to have a lower affinity for SNAREs than
CC1, which partially contributes to the speculation that CC4‐SNARE interactions
may not be functionally relevant [116]. More recent studies, however, showed that
p115 constructs that lack the CC4 domain act as a dominant‐negative on the
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structure of Golgi and cargo trafficking [114]. Thus, the CC4 domain might also play
a role in the function of p115. Whether this activity of CC4 is SNARE‐dependent
remains yet unknown.

c. Possible mechanisms of function
P115’s involvements in mammalian ER to Golgi transport, intra‐Golgi
transport, exocytosis, as well as Golgi biogenesis, have all been clearly demonstrated
[56, 94‐100]. Despite these extensive studies, however, the exact roles of p115 in
these processes have yet to be established. One theory is that p115, GM130 and
Giantin form string‐like structures via their coiled‐coil domains, in order to secure
vesicles prior to fusion [55, 84]. Also, the close association between p115 and
various SNAREs suggests that p115’s function is most likely SNARE‐related.
The fact that p115 interacts with SNAREs through its SNARE homology
domains CC1 and CC4, suggests a different mode of action than the other tethers
that bind the SNARE motif. Other SNARE motif‐binding tethers, COG component
Cog6 and GARP components Vps53 and Vps54, all have SNARE interaction domains
localized to the tethers’ N‐terminal coiled‐coils [42], which have no reported SNARE
homology. Furthermore, these tethers are capable of binding monomeric SNARE
motifs as well as assembled SNARE complexes. On the contrary, if p115 interacts
with SNAREs in a similar manner as SNARE‐SNARE interactions, it is unlikely that
p115 can stay in the SNARE complex after it is assembled, since all the SNARE‐motif
positions would have been already occupied by cognate SNAREs.
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Purified p115 appears to stimulate the assembly of SNARE complexes on
Golgi membranes, as well as the assembly of a binary complex by two purified
SNAREs [116]. Based on these findings, a ‘tweezers’ model has been proposed for
p115 [Figure 6]. When the opposing membranes are still at a distance, the tail of a
p115 dimer splits and the C‐terminus of each monomer first binds to a Giantin or
GM130 on either membrane, forming a preliminary tether bridge between the
vesicle and target membrane. As the membranes come closer, the p115 monomers
separate further, with each CC1 domains engaging a SNARE on either side. Still
joined at the head, the dimer would draw the SNAREs closer and promote the
formation of a SNARE complex [116]. Thus, p115 would act as a SNARE catalyst
during fusion, and facilitate the SNAREs to overcome a potential energy barrier
between the monomeric state and assembled state [116]. On the other hand, due to
the high affinity cognate SNAREs have for each other [14, 40, 124], it is unlikely that
the assembly of SNARE complex requires a catalyst [113]. The physiological
relevance of p115‐mediated SNAREpin assembly, therefore, remains under
speculation.
Alternatively, p115 could assemble a membrane‐bridging complex by
engaging SNAREs on both membranes through its CC1 and CC4 domains
simultaneously [125]. The dimer would not need to be split in this model. The CC1
domains of two p115 monomers would interact with either one or two SNAREs on
the same membrane, forming a three‐ or four‐helix bundle, while the joined CC4
domains engage SNARE(s) on the opposing membrane. Binding to Rab1 would
cause conformational changes in the dimer tail, which would draw the membranes
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close and/or ‘squeeze’ the bound SNAREs together. This model does not exclude the
possibility of p115 playing a role as a direct facilitator of SNARE assembly. In
addition, by ‘capturing’ SNAREs through its two SNARE‐binding domains, p115
could serve as a SNARE ‘fly paper’ and increase the local concentration of SNAREs
[125].
P115’s acidic tail is the binding site for Giantin and GM130. The function of
this tail, however, remains a controversial topic. Although the integrity of Golgi
seem to depend on the concerted effort of multiple Golgins [54, 59, 61, 108], later
studies showed that the removal of p115’s tail region does not affect Golgi ribbon
structure [113, 114]. It is possible, therefore, that p115 can carry out its function
without GM130 or Giantin, at least at certain transport compartments.
The mechanism by which p115 is recruited to membranes and promotes
SNARE assembly remains unknown. Previous studies have identified Rab1 as the
critical factor of p115 recruitment [50]. However it is not clear whether Rab1 alone
is sufficient for maintaining the membrane bound p115 population on COPII
vesicles. Later, it was discovered that upon blocking SNARE complex disassembly on
in vitro budded COPII vesicles with the addition of dominant negative alpha‐SNAP,
p115 is removed from the vesicle surface, suggesting that p115’s recruitment to
COPII vesicles is dependent upon unassembled SNAREs in addition to being Rab1
dependent [52, 100]. In vivo expression of another SNARE recycling inhibitor,
NSF/E329Q, results in decreased p115 membrane association, further suggesting
that the disassembly of SNARE complexes is important for maintaining membrane‐
bound p115 [100].
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The above findings imply that p115 preferentially binds to unassembled
SNAREs. None of these results, however, eliminates the possibility that
alpha‐SNAP/NSF competes with p115 for binding to assembled SNAREs.
Furthermore, it is presently unclear which ER‐Golgi SNAREs are required in p115
recruitment, and whether it is monomeric SNAREs as opposed to SNARE
subcomplexes of various stages that p115 binds to. Although unlikely, it is also
possible that p115 binds SNAREs to localize to sites of fusion where it performs
other functions not directly related to SNAREs.
To further complicate the matter, p115 is present throughout the early
secretory pathway, and is required in every step from COPII vesicle budding to
maintaining the Golgi stacks. Due to the highly specific protein environments in
distinct compartments, it can be assumed that p115 works with a different
assortment of cofactors from step to step. It is not clear whether p115 only employs
one mechanism of action at all its working sites, or, less likely, that it carries out
different functions at different steps in the secretory pathway. It is also unclear
whether SNAREs play similar roles at all these steps in regards to p115’s function. In
addition, due to the fact that p115 is present at more than one compartment and
therefore can not contribute to the maintenance of compartment identity simply by
its presence, it would be interesting to see if any features of p115’s mechanism of
action allow it to contribute to the specificity of vesicle targeting.
Therefore, it is essential to further characterize p115‐SNARE interactions in
detail. It would also be interesting to study p115’s role in a controlled in vitro
system, in which we could isolate the effects of each domain. Hopefully a structure‐
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function model for p115 could be derived from a combination of binding and
functional studies.
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Figure 1. Membrane trafficking pathways in the endomembrane system. ER,
endoplasmic reticulum; ERGIC, ER‐Golgi intermediate compartment, another term
for the vesicular tubular cluster (VTC); CGN, cis‐Golgi network; TGN, trans‐Golgi
network; PM, plasma membrane. Coat proteins are shown in pink.
Adapted with permission from Girard LR, Fiedler TJ, Harris TW, Carvalho F,
Antoshechkin I, Han M, Sternberg PW, Stein LD, Chalfie M. WormBook: the online
review of Caenorhabditis elegans biology. Nucleic Acids Res 2007;35(Database
issue):D472‐475.
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Figure 2: The SNARE mediated membrane fusion and the recycling of SNARE
proteins
Adapted with permission from Jahn R, Scheller RH. SNAREs‐‐engines for membrane
fusion. Nat Rev Mol Cell Biol 2006;7(9):631‐643.
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Figure 3. Golgins form fibrous matrix and capture vesicles carrying Rab
proteins.
Adapted with permission from Yu IM, Hughson FM. Tethering Factors as Organizers
of Intracellular Vesicular Traffic. Annual Review of Cell and Developmental Biology,
Vol 26 2010;26:137‐156.
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Figure 4. Tethers in the secretory pathway. A. ER‐Golgi tethers. Step 1 and 2:
P115 is recruited by Rab1 to the COPII vesicles and facilitates fusion. Step 3: Arf GEF
GBF1 activates Arf, and recruits COPI coat. Step 4: Dsl1 facilitates COPI fusion. Step
5: P115 facilitates VTCs' fusion with cis‐Golgi. Step 6: Newly formed cis‐Golgi
compartments receive COPI vesicles from more distal Golgi cisterna. Step 7: P115
and GBF1 participate in retrograde transport. B. MTCs and corresponding GTPases.
MTCs are shown in orange (secretory pathway) and red (endolysosomal system).
Rabs (yeast nomenclature) are indicated in yellow. EE, early endosome; MVB/LE,
multivesicular body/late endosome; CPY, carboxypeptidase Y, a vacuole cargo; AP‐3,
adaptor complex 3 (coatomer).
Adapted with permission from:
A. Sztul E, Lupashin V. Role of vesicle tethering factors in the ER‐Golgi membrane
traffic. FEBS Lett 2009;583(23):3770‐3783.
B. Brocker C, Engelbrecht‐Vandre S, Ungermann C. Multisubunit Tethering
Complexes and Their Role in Membrane Fusion. Current Biology 2010;20(21):R943‐
R952.
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Table 1. Golgi tethering proteins and protein complexes
Adapted with permission from Table 1, Sztul E, Lupashin V. Role of vesicle tethering factors in the ER‐Golgi
membrane traffic. FEBS Lett 2009;583(23):3770‐3783.
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Figure 5. Model of the overall fold of the fulllength p115. Surface and cartoon
representations of a model of the full‐length p115 generated by manually fitting a
coiled‐coil of appropriate length to the C‐termini of p115GHR in the crystallographic
dimer. P115GHR: p115 globular head region; p115CC: p115 coiled‐coil region.
Adapted with permission from Striegl H, Roske Y, Kummel D, Heinemann U. Unusual
armadillo fold in the human general vesicular transport factor p115. PLoS One
2009;4(2):e4656.
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Figure 6: A sequence of events in the ‘tweezers’ model of p115 function.
Adapted with permission from Shorter J, Beard MB, Seemann J, Dirac‐Svejstrup AB,
Warren G. Sequential tethering of Golgins and catalysis of SNAREpin assembly by
the vesicle‐tethering protein p115. J Cell Biol 2002;157(1):45‐62.
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Chapter II: Methods
A. Protein Purification
Recombinant SNARE proteins were expressed and purified as previously
described [29]. Hexahistidine‐tagged full‐length bovine p115 was expressed in E.
coli strain NM522 using a pQE9 construct obtained from the Lowe lab [84]. Bacteria
cultures were grown at 37°C to an A600 of 0.4, before induction with 1 mM isopropyl‐
1‐thio‐β‐D‐galactopyranoside at the same temperature for 2‐3 hours. Bacteria were
pelleted and resuspended in French Press buffer (50 mM Tris, pH 8.0, 0.1 M NaCl, 1
mM EDTA, 0.05% Tween 20, 2 μg/ml leupeptin, 4 μg/ml aprotinin, 1 μg/ml
pepstatin A, and 1 mM phenylmethylsulfonyl fluoride). After 2 rounds of French
Press, cell lysates were centrifuged at 20,000 x g for 20 minutes, the supernatant
was then collected and centrifuged again at 100,000 x g for 45 minutes. Supernatant
from the second centrifigation was passed through a Ni‐NTA column equilibrated
with 50 mM Tris, pH 8.0, 0.3 M NaCl, 0.05% Tween 20, and 0.025 M imidazole, and
eluted with the same buffer containing a 0.025‐0.25 M gradient of imidazole.
Purified His‐tagged p115 was dialyzed into protease inhibitors (1 mM DTT, 2 μg/ml
leupeptin, 4 μg/ml aprotinin, and 1 μg/ml pepstatin A) supplemented Buffer A (20
mM Hepes, pH 7.2, 0.15 M KCl, 2 mM EDTA, 5% glycerol), and quantitated according
to A280. Sec22b N‐terminal domain was present as a major degradation product in
the sec22b preparation, and was separated from the full‐length protein by gel
filtration. Hexahistidine‐tagged membrane N‐terminal domain and hexahistidine‐
tagged Ykt6 N‐terminal domain were expressed using pQE9 constructs and purified
in the same way as full‐length sec22b.
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For the in vitro tethering and fusion assay, Ni‐NTA purified p115 was further
purified on an ion exchange column (FPLC‐Mono Q, Amersham Pharmacia Biotech).
The column was washed abundantly with running buffer (20 mM Tris, 1mM EGTA,
pH 7.6). After loading p115, the column was washed with 15 ml running buffer, then
eluted with the same buffer containing a 0‐1 M gradient of KCl. Purified p115 was
dialyzed into 25 mM Hepes, 125 mM potassium acetate, pH 7.2.
p115 from rat liver cytosol was partially purified by two procedures. The
first procedure essentially followed [95], with minor modifications; this generated a
MonoQ fraction with a simple protein pattern in which p115 is a major band by SDS
gel and Coommassie staining. A second procedure involved ammonium sulfate
fractionation as in Barroso et al., followed directly by Superdex 200 gel filtration.
The peak Superdex 200 fraction was quite complex, but was enriched for p115 by
18‐fold relative to cytosol.

B. Gel Filtration Chromatography
Individual purified recombinant SNAREs were either loaded onto a gel
filtration column alone, or loaded after incubation with p115. Eluted fractions were
collected, acetone precipitated and analyzed by SDS‐PAGE and Western blotting
[Figure 7].
The gel filtration column use for this study is a pre‐packaged 24‐ml Superdex
200 (Amersham Pharmacia Biotech). By comparing the elution of the SNARE/p115
mixture, and the SNARE only elution, we will be able to determine whether the
SNARE in question has entered into a complex with p115, indicated by a shift of the
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elution peak. It is worth noting that due to p115’s elongated shape, it is eluted as a
~700kD protein. This is normal for the p115 dimer, as described in literature [56].
For the p115‐monomeric SNARE binding assay [Figure 12A‐I], approximately
20 μg of each full‐length SNARE protein or NT domain was incubated with or
without ~1.3 μM of p115 in Buffer A supplemented with 0.1 % Triton X‐100, in a
reaction volume of 300 μl. After an overnight incubation, 250 μl of each protein mix
was fractionated on the gel filtration column equilibrated in Buffer A containing 0.5
mg/ml BSA and 0.1% Triton X‐100. Fractions were acetone‐precipitated and
subjected to SDS‐PAGE and Western analysis with anti‐SNARE antibodies.
For the SNARE monomer vs. complex binding assay [Figure 14], all reactions
were conducted in the same buffer used in other gel filtration experiments. Purified
recombinant rbet1, syntaxin 5, and membrin were incubated together on ice for 48
hrs, before loading onto 5–30% glycerol gradients run in Buffer A supplemented
with 0.1% Triton X‐100, then centrifuged at 200,000 x g for 24 hrs in a Beckman
MLS‐50 rotor. Rbet1 alone was also subjected to velocity sedimentation under the
same conditions. Fractions from both gradients were analyzed and quantitated with
anti‐rbet1 Western analysis, complex and monomer fractions were each pooled and
dialyzed into Buffer A containing 0.1% Triton X‐100.
In the SNARE complex assembly assay [Figure 17], for the instantaneous
effects of p115 [Figure 17 A and C, left panel], 50 μl of purified recombinant syntaxin
5, membrin, rbet1, and sec22b were incubated together on ice for 4 hrs, in the
presence or absence of 0.9 μM of p115. The reactions were subjected to gel filtration
as described above. The fractions were acetone‐precipitated, dissolved in sample
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buffer and analyzed with Western blotting for sec22b.
For the chaperone effects studies [Figure 17B and C, right panel], 50 μl of
purified recombinant sec22b was incubated with p115 overnight on ice, before the
addition of syntaxin 5, membrin, and rbet1. The final p115 concentration in the
reaction mix was 0.9 μM. For the control reaction, sec22b was incubated alone on
ice overnight, before the addition of other SNAREs and 0.9 μM of p115. Both
reactions were incubated on ice for 4 hrs, then subjected to gel filtration, SDS‐PAGE,
and Western analysis for sec22b as described above.

C. Bead Binding Assay
GST tagged recombinant SNAREs were fixed onto glutathione‐Sepharose
beads, and incubated with p115. The beads were then washed and analyzed by SDS‐
PAGE and Western blotting. Retention of p115 or, in the case of the p115
displacement experiment, the amount of p115 in solution was compared to the GST
control beads.
For the SNARE‐p115 binary binding experiments [Figures 8 and 13], 100 μl of
50% glutathione‐Sepharose beads containing 0.5 mg/ml membrin, rbet1, or GST
was each incubated with 20 nM and 60 nM of p115, respectively, in the presence of
Buffer A containing 1 mg/ml BSA and 0.1% Triton X‐100. Reaction volume was 200
μl. All reactions were incubated at 4°C overnight with agitation. Beads were then
pelleted and washed with 3 x 1 ml of the same reaction buffer, after which 50 μl of
SDS‐PAGE sample buffer was added to each pellet prior to SDS‐PAGE and Western
analysis. For bead binding assays shown in Figure 20, only 20 μl of beads were used
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per 200 μl reaction, but the other parameters were similar.
For the p115 displacement experiment [Figures 9 and 15], reactions were
conducted in the same buffer as the binary binding experiments. 100 μl of 50%
glutathione‐Sepharose beads containing 0.5 mg/ml rbet1 or GST was incubated with
600 nM p115 at 4°C overnight with agitation. The next day, after washing the beads
with 3 x 1ml of reaction buffer, 0.025, 0.05, or 0.075 mg/ml of membrin or BSA was
added to the reactions. All reactions were then incubated at 4°C for 4 hrs with
agitation. The supernatants were collected and supplemented with equal volume of
sample buffer, before subjected to SDS‐PAGE and Western analysis for p115.

D. In vitro Budding, Tethering and Fusion Assays
Our lab has developed a method to generate and study the fusion and
tethering of COPII coated compartments in vitro [Figure 10]. This assay utilizes the
vesicular stomatitis virus glycoprotein (VSV‐G) ts045 as a model cargo. Normal rat
kidney cells were either transfected with myc‐VSV‐G DNA, or infected with VSV then
pulse radiolabeled. Following an incubation at 40°C that allows VSV‐G to accumulate
in the ER, both populations of cells were permeabilized and incubated in the
presence of rat liver cytosol, ATP regenerating system, and buffer, thus producing
two distinctly labeled, fusogenic COPII vesicle populations.
Due to an equilibrium between VSV‐G trimers and monomers [126], fusion of
the differently labeled vesicles will result in a heterotrimer containing both the myc‐
labeled VSV‐G monomer and the S35 labeled VSV‐G* monomer. This kind of
heterotrimer can only arise from fusion, but not tethering of the vesicles. This
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property of the VSV‐G trimer allows us to study the events of fusion and tethering
separately in our in vitro assay.
NRK cells were transfected with myc‐VSV‐G DNA. After 24 hrs, cells were
infected with vaccinia virus, followed by a 5 hr incubation at 40oC. The cells were
then permeabilized by scraping and suspended in 25/125 buffer. Myc‐labeled
vesicles were produced in a buffer consisting of 75 μl of the cell suspension, 96 μl of
water, 65 μl of 25/125 buffer, 15 μl of 0.1 M magnesium acetate, 30 μl of ATP‐
regenerating system, 9 μl of 1 M HEPES, pH 7.2, 60 μl of Ca/EGTA buffer (20 mM
HEPES, pH 7.2, 1.8 mM CaCl2, and 5 mM EGTA), and 150 μl of rat liver cytosol
dialyzed in 25/125 buffer. After incubation at 32°C for 30 minutes, cells were
removed from the reactions by centrifigation. 160 μl of recombinant rbet1 (~2.5 μg)
in Buffer A, 160 μl of Buffer A, or 160 μl of 25/125 buffer (positive control) was then
added to the vesicles. Reactions were incubated on ice for 20 minutes prior to
another 1 hr incubation at 32°C, after which vesicles were immunoisolated with 5
μg of anti‐myc mAb, and subjected to SDS‐PAGE and Western analysis.
COPII vesicle co‐isolation and heterotrimerization assays were also carried out
as previously described. Two distinctly labeled COPII vesicle populations were
generated for these assays. Myc‐VSV‐G‐containing vesicles were prepared as
described above. To prepare the 35S‐labeled vesicles, NRK cells were transfected
with vesicular stomatitis virus strain ts045 and incubated at 32oC for 4 hrs, before
labeling with 500 μCi of 35S‐cysteine/methionine at 40°C, in a cysteine/methionine‐
free medium. Cells were then permeabilized and suspended in 25/125 buffer. Both
types of vesicles were produced in a reaction mix consists of 337.5 μl of either cell
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suspension, 432 μl of water, 67.5 μl of 0.1 M magnesium acetate, 135 μl of ATP‐
regenerating system, 40.5 μl of 1 M HEPES, pH 7.2, 270 μl of Ca/EGTA buffer, and
675 μl of rat liver cytosol (either untreated, mock‐depleted, or p115‐depleted, all
dialyzed in 25/125 buffer). Supernatants containing COPII vesicles were collected
by centrifigation. 72.5 μl of myc‐VSV‐G vesicle suspension and 72.5 μl of 35S‐VSV‐G
vesicle suspension were added to each reaction tube. For certain reactions,
recombinant p115 dialyzed in 25/125 was also added. The final volume of all
reactions was brought up to 200 μl with 25/125 buffer. Reacion tubes were first
incubated on ice for 20 minutes, then shifted to a 32°C water bath and incubated for
another 1 hr.
Treatments for fusion versus tethering assays differ from this point on. For the
tethering/co‐isolation assay, the reactions were chilled and centrifuged at 20,000 x
g for 5 minutes to remove large vesicles, then immunoisolated with 5 μg of
biotinylated anti‐myc mAb and 10 μl 50% streptavidin‐Sepharose (GE Healthcare).
The isolates were dissolved in sample buffer, run on 12% SDS‐PAGE gels, and
transferred to nitrocellulose membrane. The amount of myc‐VSV‐G in each isolate
was quantitated by Western analysis. The membrane was then dried and analyzed
by phosphorimaging. Amounts of 35S were measured, and normalized based on the
myc‐VSV‐G level, which reflects the amount of vesicle present. For the vesicle fusion
assay, 2% Triton X‐100 was added to the reactions following the 1 hr incubation at
32°C. Reactions were then incubated with agitation at 4°C for 20 minutes, before
centrifugation at 100,000 × g for 30 min. Immunoisolation and analysis were
performed on the supernatants as described for the tethering assay.
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To generate p115‐depleted cytosol, Pansorbin beads (Calbiochem) were
washed five times with 50 x volume 25/125 buffer (25 mM Hepes, 125 mM
potassium acetate, pH 7.2), and re‐suspended at a concentration of 10%. Rat liver
cytosol was dialyzed into 25/125 buffer, then supplemented with 0.05 x volume of
affinity‐purified rabbit anti‐p115 (see below) and incubated at 4°C for 2 hrs.
Immediately after the incubation, Pansorbin suspension was added to the cytosol at
a concentration of 0.06 x volume. The mixture was incubated with agitation at 4°C
for 15 minutes, before centrifugation at 20,000 x g. The supernatant was centrifuged
again at 20,000 x g. Supernatant from the second centrifugation was then collected.
In addition, a mock‐depleted RLC was produced using identical methods and non‐
immune rabbit IgG.

E. Endoglycosidase H Acquisition Assay
During ER‐Golgi transport, a fourteen‐subunit oligosaccharide linked to a
cargo protein is modified at the Golgi by Golgi alpha‐mannosidase II, and the protein
acquires Endo H resistance by this process. Therefore, the percentage of Endo H
resistant population of a select cargo reflects the efficiency of ER‐Golgi transport of
the glycoprotein cargo [127].
For the ER‐Golgi transport assay, to reduce the p115 ‘background’, NRK cells
were electroporated with p115 siRNA (Ambion, Silencer Select; 5’‐
CUAUUGACGCAACAGGUAAtt‐3’) twice over five days prior to assays. NRK cells were
then infected with VSV‐G, shifted to 40°C and pulse‐radiolabeled with 35S‐labeled
amino acids. The cells were permeabilized as describe above in the fusion assay, and
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reconstituted with rat liver cytosol, various other soluble proteins, and an ATP‐
regenerating system, then incubated at 32°C to allow ER to Golgi transport to occur.
Incubated semi‐intact cells were dissolved in detergent and proteins were digested
with or without endoglycosidase H. The endoglycosidase H‐resistant VSV‐G in each
sample was determined following gel electrophoresis and autoradiography. Percent
endoglycosidase H resistance of VSV‐G, the measure of ER to Golgi transport, was
defined as the intensity of the endoglycosidase H resistant band divided by the sum
of the resistant and sensitive bands x 100%.

F. P115 Depletion and Overexpression in HeLa Cells
For the overexpression of p115, HeLa cells were transfected with full‐length
myc‐tagged p115. For the depletion of p115 and subsequent rescue, Hela cells were
transfected with anti‐human p115 siRNA for 3 days and then transfected with myc‐
tagged rat full‐length p115. SiRNA and construct design, transfection, and
immunofluorescence microscopy were all performed as previously described [114].

G. Antibody Production
Hexahistidine‐tagged rat p115 construct was expressed in E. coli with pET‐21b
vector. Cultures were grown at 37°C to an A600 of 0.5, before induction with 0.5 mM
isopropyl‐1‐thio‐β‐D‐galactopyranoside at the same temperature for 3 hours.
Harvested cells were subjected to two rounds of French Press and centrifuged at
20,000 x g for 20 minutes. The supernatant was then collected and centrifuged again
at 100,000 x g for 45 minutes. Pellets from the second centrifigation were collected
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and dissolved in sample buffer and loaded onto SDS‐PAGE gels. Gels were stained
with 0.1% Commassie in water, and the resolved p115 bands were excised from the
gel and subjected to electroelution in 25 mM Tris, 191 mM glycine, 0.1% SDS, and 1
mM DTT. The eluted protein solution was concentrated and injected subcutaneously
into a rabbit using Freund's adjuvant. Collected sera were supplemented with equal
volume of 10 mM Tris, pH 7.5, filtered with syringe filter, and passed through a
CNBr‐Sepharose column conjugated with GST as nonspecific control. The
flowthrough was then loaded onto another CNBr‐Sepharose column conjugated
with rat p115. After sample loading, columns were washed with 3 x 5ml of 10 mM
Tris, pH 7.5, then washed with the same buffer containing 0.5M NaCl, once again
with 10 mM Tris, pH 7.5, and finally eluted with 0.1M glycine, pH 2.5. Fractions were
neutralized with 2M Tris, pH 8.0, and quantitated at A280. Peak fractions were
pooled and dialyzed into 25/125 buffer.
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Figure 7: General procedure of the gel filtration assay.
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Figure 8: SNAREp115 binary bead binding experiment.
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Figure 9: P115 displacement bead binding experiment.
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Figure 10: The in vitro COPII vesicle budding, tethering, and fusion system.
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Chapter III. P115 Selectively Binds Monomeric SNAREs
A. P115’s Interactions with Individual ERGolgi SNAREs
Previous studies demonstrated that p115 coprecipitates with syntaxin 5,
membrin, bet1p (rbet1), and sec22b [50, 116], yet direct and specific binding
interactions between p115 and these SNAREs, individually and as subcomplexes,
have not been explored. Detailed knowledge of these interactions is key to
understanding the p115 mechanism of action. To study directly p115’s interactions
with SNAREs, we first prepared soluble ER‐Golgi SNARE proteins. Cytoplasmic
domains of rat ER/Golgi SNAREs sec22b (residues 2‐196), syntaxin 5 (the shorter
isoform, representing residues 55‐333 of the longer isoform), and rbet1 (residues 1‐
95) were expressed in E. coli and purified using column chromatography as
described before [29]. We were unable to express the cytoplasmic domain of
membrin in E. coli, but a full‐length membrin construct (residues 2‐212) was well‐
expressed, soluble in mild detergent and active in binding studies. His6‐tagged full‐
length bovine p115 was also well expressed and freely soluble, and was purified by
column chromatography. This p115 preparation has been previously shown to be
active in SNARE interaction assays [84]. Figure 11 shows an SDS gel analysis of the
protein preparations typically used in these studies.
Our binary binding studies utilized a gel filtration assay that only detects
stable complexes formed in solution. Purified p115 was passed through a Superdex
200 column. Due to its elongated shape, the peak of p115 elution was in fraction 10
(Figure 12A), at a predicted size of 700 kD, much larger than the expected 230 kD
dimer, as shown previously [56]. This unusual feature of p115 made a gel filtration
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SNARE binding assay feasible since the p115 elution did not overlap with SNARE
complexes or homo‐oligomers. Next, soluble syntaxin 5, membrin, rbet1, and sec22b
were passed through the Superdex column separately, fractions were collected and
analyzed by Western blotting. Rbet1, sec22b, syntaxin 5 and membrin were eluted
in fractions 28‐34, 26‐36, 18‐30, and 16‐30, respectively (Figure 12B‐E, top panels,
slightly different fractions are shown to optimize display of each protein). The
SNAREs were then each incubated separately with p115 overnight on ice, the
reactions were subjected to gel filtration and analyzed by Western using anti‐SNARE
antibody. The elution of each mixed incubation (Figure 12B‐E, bottom panels) was
compared to the SNARE‐only elution (top panels). In the presence of p115, a
significant portion of both rbet1 and sec22b shifted to higher molecular weight
fractions, indicating the formation of a complex. Furthermore, the elution peaks of
the complexes overlapped the p115 peak, suggesting the presence of p115 in these
complexes. Since the p115/SNARE complexes overlapped the void volume of the
column, especially in the case of sec22b (part C), we independently verified the
presence of freely soluble p115‐sec22b complexes by centrifuging the co‐incubated
proteins at 100,000 x g to remove high molecular weight aggregates followed
immediately by co‐immunoprecipitation of the two proteins using anti‐p115
antibody (Figure 12J).

B. SNARE Motif is the Binding Site for P115
Structurally, a typical SNARE consists of an N‐terminal domain, a SNARE motif,
and a membrane anchor [12]. Most SNARE‐binding tethering complexes such as the
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Dsl1 complex, Golgi‐associated retrograde protein (GARP) complex and homotypic
vacuole fusion and protein sorting (HOPS) complex, primarily interact with the N‐
terminal domain of SNAREs [70, 77, 78, 128, 129], whereas the conserved
oligomeric Golgi (COG) complex preferentially interacts with the SNARE motif of
Sed5p [87]. The CC1 and CC4 domains of p115 share weak sequence homology to
the SNARE motif [116, 130], and it has been demonstrated that p115 interacts with
SNAREs through these two domains [113, 114, 116]. The binding site for p115 on a
SNARE has not been mapped before, but we expected that p115 binds the SNARE
motif through coiled‐coil interactions, similarly to SNARE‐SNARE binding. As one
demonstration of this principle, rbet1 is a SNARE that lacks the N‐terminal domain,
meaning that the cytoplasmic portion of rbet1 (residues 1‐95) employed in our
binding studies consists solely of the rbet1 SNARE motif. Since p115 and the SNARE
motif of rbet1 formed a stable complex that can be resolved by gel filtration (Figure
12B), the SNARE motif must be the binding site for p115.
However, these results do not exclude the possibility that p115 can also
interact with a SNARE’s N‐terminal domain. Sec22b has an unusual N‐terminal
structure composed of a β‐sheet and several α‐helices termed the longin domain
[32]. Similar structures of other SNAREs have been reported to bind SNARE motifs
and exert regulatory effects on SNARE activities [131‐133] and localization [34]. The
longin domain of sec22b contains two potential binding grooves for the SNARE
motif, although intramolecular binding has not been clearly demonstrated. To test
possible interactions between p115 and the sec22b longin domain, we expressed
and purified the N‐terminal longin domain of sec22b. We did not detect any binding
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between the sec22b longin domain and p115 using the gel filtration assay (Figure
12G), which provides additional support that p115 interacts with the SNARE motif.
In addition, we also purified the N‐terminal regions of membrin, that possesses a
three‐helix N‐terminal domain [134, 135], and Ykt6, another ER‐Golgi SNARE that
possesses a longin domain that has been shown to interact with SNARE motifs [34,
131], and tested their binding to p115. No binding was detected between p115 and
either construct (Figure 12H, I).

C. P115 Interacts with Monomeric SNAREs, but not SNARE Complexes
We noted that membrin and syntaxin 5, two SNAREs that have been shown
to interact with p115 using a bead‐binding format [50, 116], did not form stable
complexes with p115 under our binding conditions (Figure 12, D and E.). One
obvious possibility is that the syntaxin 5 and membrin N‐terminal domains bound
their respective SNARE motifs, precluding p115 access. The syntaxin 5 N‐terminal
domain has been shown to reduce other SNARE binding [29]. To test for potential
interference by the syntaxin 5 N‐terminal domain, a highly active construct
consisting of only the SNARE motif of syntaxin 5 (residues 252‐333) was generated
by thrombin cleavage of the cytoplasmic domain (residues 55‐333), and purified by
velocity sedimentation. This fragment of syntaxin 5 was demonstrated to be at least
an order of magnitude more efficient in SNARE complex formation than the full
cytoplasmic form [29]. However, when we used the truncated construct in gel
filtration studies, we were unable to detect binding between p115 and the syntaxin
5 SNARE motif (Figure 12F).
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Perhaps relevant to their lack of binding, we also noticed that both membrin
and syntaxin 5 eluted in fractions in the 150‐200 kD range, much larger than their
expected monomer molecular weights of 25 and 34 kD, respectively. For reference,
the syntaxin 5‐membrin‐rbet1‐sec22b 1:1:1:1 complex in this system elutes in
fraction 17 with a calibrated molecular weight of ~300 kD [29]. Apparently, under
our purification conditions, syntaxin 5 and membrin form homo‐oligomeric coiled‐
coils in solution. Furthermore, p115’s binding could have been prevented by this
oligomerization.
These results left two possibilities to explain the lack of p115 binding to
syntaxin 5 and membrin; 1) p115 does not form stable complexes with SNARE
oligomers or 2) p115 is selective for binding certain SNAREs, and does not interact
with syntaxin 5 and membrin. However the latter possibility seems unlikely since
interactions between p115, syntaxin 5, and membrin have been observed [50, 116].
More likely, our particular protein preparations and/or gel filtration binding assay
are able to detect a binding preference for monomeric SNAREs that had not been
apparent before.
To further analyze possible interactions between p115 and membrin, and to
understand the basis for the potential discrepancy with the literature, GST‐tagged
full‐length membrin was immobilized on Glutathione‐Sepharose beads, along with
GST or GST‐rbet1 for negative and positive controls, respectively. These beads were
then incubated with p115, washed, and the levels of bound p115 were analyzed by
SDS‐PAGE and immunoblotting (Figure 8). By using this bead‐binding assay, we
were able to demonstrate specific binding between p115 and membrin beads
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(Figure 13). However, unlike GST‐rbet1, GST‐membrin bound only at higher p115
concentrations at which nonspecific binding was also evident. Since a higher affinity
interaction is more likely to be solution‐stable, this likely explains why membrin
and syntaxin 5 failed to produce complexes in the gel filtration assay, and suggests
that the discrepancy we saw was due to different experimental conditions.
In summary, p115 bound stably to rbet1 and sec22b in solution, but did not
form stable complexes with membrin or syntaxin 5 (Figure 12). The low affinity
interactions observed with membrin in the bead format, together with the fact that
p115 did not stably interact with the highly active syntaxin 5 SNARE motif led us to
hypothesize that oligomerization was the main reason for p115’s apparent
selectivity in the gel filtration binding assay. If this is true, then the formation of a
hetero‐oligomeric SNARE complex, which is structurally even more robust than
SNARE homo‐oligomers, is predicted to also block the binding of p115.
Since the formation of a SNARE complex does not involve the SNARE N‐
terminal domains, it is not surprising that tethers associating with SNARE N‐
terminal domains can remain bound to the SNARE complex after its completion
[70]. However, it is harder to imagine p115, which interacts with SNARE motifs, not
being displaced after the SNARE motifs assemble into a four‐helix‐bundle. Studies
have demonstrated that despite its involvement in SNARE assembly, p115 can be
washed off with high salt from formed SNARE complexes, indicating that p115 is not
integrated into these complexes [116]. P115/Uso1p‐facilitated SNARE assembly
yields SNARE complexes lacking p115 [96, 116]. Furthermore, blocking the
recycling of SNAREs decreases the amount of membrane‐associated p115 [52],
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suggesting SNARE complexes cannot recruit p115 as efficiently as SNAREs in
monomeric form.
To test whether p115 can interact with SNARE complexes, we performed a
solution binding study using rbet1 in its hetero‐oligomeric vs. its monomeric state.
Recombinant rbet1, syntaxin 5 and membrin were incubated together prior to
fractionation by velocity gradient sedimentation. The presence of rbet1‐containing
SNARE complexes in fraction 7 was detected by anti‐rbet1 immunoblotting and then
confirmed by gel filtration followed by immunoblotting. The velocity gradient‐
purified rbet1‐containing t‐SNARE complex was found in gel filtration fractions 16,
17, and 18 (Figure 14, step 2, upper right panel). As was established in previous
studies, these fractions contain predominantly rbet1‐syntaxin 5‐membrin ternary
complexes, as well as some rbet1‐membrin and rbet1‐syntaxin 5 binary complexes.
[29]. As a control, soluble rbet1 alone was also subjected to velocity sedimentation,
and fractions containing the monomeric rbet1 were pooled and adjusted to a
comparable rbet1 concentration as in the SNARE complex fraction. Gel filtration of
this fraction confirmed its monomeric state (Figure 14, step 2, upper left panel).
Next, the velocity gradient‐purified ternary SNARE complex and monomeric rbet1
were separately incubated with p115 prior to gel filtration chromatography. As
expected, an rbet1‐p115 complex was detected in fractions 10‐14 (Figure 14, step 2,
middle left panel) when p115 was incubated with monomeric rbet1. However, there
was little detectable binding between p115 and the t‐SNARE complexes containing
rbet1 of similar concentration (Figure 14, step 2, middle right panel). This is the first
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direct demonstration that p115 binds stably to a monomeric SNARE but not to the
same SNARE when integrated into a SNARE bundle.
Although we cannot exclude that there was a small amount of binding
between p115 and the rbet1‐syntaxin 5‐membrin complex, two experimental
factors argue that any such binding was orders of magnitude lower than binding to
rbet1 monomers. First, there was some monomer present in the purified complex
preparation (Figure 14, step 2, upper right panel, fraction 32). This could account
for a slight binding of that preparation to p115 based on a p115‐rbet1 binary
interaction. Second, the ternary complex preparation is composed primarily of the
more binding‐active form of rbet1, which is the more rapidly migrating form on
SDS‐PAGE. Although the structural basis of the two closely‐migrating forms is
unclear, they are observed in both E.coli‐produced as well as endogenous cell
extracts [136], with the faster‐migrating form exhibiting greater SNARE binding and
recruitment to COPII vesicles. The relative efficiency of binding to p115 of the
monomer preparation is vastly greater than that of the ternary preparation when
only the lower rbet1 band is considered.

D. Membrin Displaces P115 from a Preformed Rbet1P115 Complex
Because p115 is not part of the final SNARE complex, we hypothesized that in
order for the SNARE assembly to complete, p115 would need to dissociate from its
bound SNAREs. To confirm this prediction, GST‐rbet1 or control GST were
immobilized on Glutathione‐Sepharose beads, then incubated with p115 to allow
the formation of a GST‐rbet1‐p115 complex (Figure 9). After several rounds of
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washing to rinse off unbound p115, the beads were incubated either with an excess
amount of soluble membrin, or with bovine serum albumin (BSA) as a control. After
this incubation, supernatants were collected and the amount of dissociated p115
found in the supernatant was analyzed by immunoblotting. P115 was eluted from
the GST‐rbet1‐p115 beads by membrin in a dose‐dependent manner; furthermore,
this elution effect pertained to p115 specifically bound to GST‐rbet1 beads and not
to GST beads (Figure 15A top vs. bottom panels, and quantitated in B). On the other
hand BSA had only a small, presumably nonspecific effect on the rbet1‐p115
complex that appeared to pertain to non‐specifically bound p115 present on either
GST or GST‐rbet1 beads (Figure 15A, left panels, and quantitated in B).

E. Monomeric SNAREs are a Required Binding Site for P115 on COPII Vesicles
P115 is still associated with membrane in the absence of active Rab1 GTPase
[100], suggesting an additional binding site for p115 on the COPII vesicle
membrane. SNAREs have been shown to play an essential role in the recruitment of
p115 to COPII vesicles [52], yet it is unclear which SNARE species are responsible
for this recruitment. So far we have demonstrated that p115 selectively binds to
monomeric SNAREs but not SNARE complexes using solution‐binding assays, and
here we test the hypothesis that p115 requires monomeric SNAREs for its retention
on in vitro generated COPII vesicles. This assay utilizes the vesicular stomatitis virus
glycoprotein (VSV‐G) ts045 as a model cargo. Normal rat kidney (NRK) cells were
transfected with myc‐VSV‐G DNA and cultured at 37°C. Following a subsequent
incubation at 40°C that allows VSV‐G to accumulate in the ER, cells were
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permeablized and incubated in the presence of rat liver cytosol, an ATP
regenerating system, and buffer, allowing them to produce COPII coated vesicles
with a cytoplasmically accessible myc tag. These vesicles were incubated in the
presence or absence of recombinant soluble rbet1, then immuno‐isolated using anti‐
myc antibody beads (Figure 16A). The amount of p115 present on the vesicles, as
well as internal membrane markers, was analyzed by immunoblotting. Compared to
the control, the addition of excess soluble rbet1 removed all detectable p115 from
the COPII vesicles (Figure 16B). The fact that a soluble SNARE alone can compete
p115 off vesicle membranes suggests that monomeric SNAREs account for the p115
interactions with COPII vesicles—or at least for those ongoing p115 interactions
strong enough to withstand the immuno‐isolation of vesicles. This finding is
consistent with, but more direct than previous studies showing that an inhibition of
SNARE complex disassembly impairs p115‐membrane association [52, 100].
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Figure 11. Purified recombinant SNAREs and p115. Proteins were separated on a
15% SDS‐PAGE gel, and stained with Coommassie Blue. Protein loads correspond to
the relative amounts used in gel filtration binding assays. Rbet1 (residues 1‐95)
runs below the 14 kD marker and contains sub‐stoichiometric GST contaminants
around the 24 kD marker. Syntaxin 5 (residues 55‐333) runs between the 29 and 36
kD markers (marked by an asterisk) and contains heavy GST contamination around
the 24 kD marker. A C‐terminal truncation product of syntaxin 5 lacking the SNARE
motif (residues 55‐251) runs between the 24 and 29 kD markers. Bands above the
45 kD marker represent uncleaved GST fusion proteins and their C‐terminal
truncation products. The full‐length membrin band between 24 and 29 kD markers
is largely free of contaminating GST but contains sub‐stoichiometric unknown
truncation or degradation products. His6‐sec22b between the 20 and 24 kD
markers is largely homogeneous. His6‐p115 runs above the 97 kD marker and
contains various unknown C‐terminal truncation products and a substantial
contaminant near the 24 kD marker (see Fig. 17B for detail).
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Figure 12. Binary interactions of p115 with ERGolgi SNAREs rbet1 and
sec22b, but not syntaxin 5, membrin, or SNARE Nterminal domains. Soluble
recombinant p115, syntaxin 5, membrin, rbet1, and sec22b were passed through a
Superdex 200 column separately, fractions were collected and analyzed by Western
blotting. The SNAREs were then each incubated separately with 1.3 μM p115
overnight on ice, the reactions were gel‐filtered and analyzed by Western using anti‐
SNARE antibody. (A) P115 only elution. (B) Rbet1 only (top) and rbet1‐p115
reaction mix (bottom) elutions. (C) Sec22b only (top) and sec22b‐p115 reaction mix
(bottom) elutions. (D) Syntaxin 5 only (top) and syntaxin 5‐p115 reaction mix
(bottom) elutions. (E) Membrin only (top) and membrin‐p115 reaction mix
(bottom) elutions. (F) Syntaxin 5 (residues 55‐333) was subjected to thrombin
cleavage. The SNARE motif (residues 251‐333) was purified by velocity
sedimentation on 5–30% glycerol gradients. Top panel: Syntaxin 5 SNARE motif
only elution. Bottom panel: Elution of syntaxin 5 SNARE motif‐p115 reaction mix.
Hexahistidine‐tagged N‐terminal domain constructs of sec22b, membrin, and Ykt6
were expressed in E. coli and purified by nickel‐affinity chromatography (see
Materials and Methods). Sec22b NT (G), membrin NT (H), and Ykt6 NT (I) were
passed through gel filtration column separately (top panels). Each protein was then
incubated with p115 and then the mixed reactions were gel‐filtered and
immunoblotted with anti‐SNARE antibodies (bottom panels). Gel filtration fraction
numbers are shown above top panels. Elution positions of Dextran 2000 (void),
native thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), and BSA (67
kDa) are indicated with arrows above the fraction numbers. (J) sec22b and p115
were co‐incubated as in part C, centrifuged at 100,000 x g to remove potential
aggregates, and then precipitated using α‐p115 antibody beads. The presence of
specifically co‐precipitated sec22b demonstrates the presence of a soluble p115‐
sec22b complex. “*” marks IgG heavy chain; “**” marks a contaminant in the p115
preparation that cross‐reacts with the anti‐sec22b antibody.
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Figure 13. P115 binds to beadimmobilized GSTrbet1 with higher affinity
than GSTmembrin. (A) Binary bead‐binding experiments were carried out as
described in MethodsP115 binding to GST, GST‐rbet1, and GST‐membrin beads, at
the two assayed concentrations. (B) Ponceau S staining of membrane demonstrate
that similar amounts of bead‐immobilized fusion proteins were present in each
reaction.
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Figure 14. P115 binds monomeric rbet1, but not tSNARE complexes
containing rbet1. Recombinant rbet1 was incubated with recombinant syntaxin 5
and membrin overnight on ice to allow the formation of SNARE complexes. Reaction
mix was loaded onto a 5–30% glycerol gradient, and subjected to velocity
sedimentation (Step 1). The presence of t‐SNARE complexes in fraction 7 was
confirmed by Western blotting (data not shown). Recombinant rbet1 alone was also
subjected to velocity sedimentation, and fractions containing monomeric rbet1 were
pooled and adjusted to a similar rbet1 concentration as the SNARE complex (for
simplicity this is depicted as a pool of those fractions from the complexes gradient).
Both monomeric rbet1 and SNARE complex were passed through a gel filtration
column, with fractions analyzed by Western blotting using an anti‐rbet1 antibody
(Step 2, top panels). Monomeric rbet1 and the SNARE complex were incubated with
p115 separately, the mixed reactions were gel‐filtered and analyzed by Western
blotting using the same antibody (Step 2, middle panels). P115 in the mixed
reaction fractionation was also detected by immunoblot (Step 2, bottom panels).
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Figure 15. Soluble membrin displaces p115 from a preformed p115rbet1
complex. Displacement experiments were carried out as described in Methods. In
short, GST or GST‐rbet1 was immobilized on glutathione‐Sepharose beads. Beads
containing 0.5 mg/ml GST‐rbet1 or GST were then incubated with 600 nM p115 at
4°C overnight to allow the formation of p115‐rbet1 complexes. After thorough
washing, increasing concentrations of membrin or control BSA were added to the
p115‐treated beads. Following an incubation of 1 hr at 4°C, beads were centrifuged,
supernatants were harvested, and p115 present was analyzed by SDS‐PAGE and
Western blotting. (A) Amounts of p115 present in the supernatants from GST beads
(bottom panels) or GST‐rbet1 beads (top panels) incubated with BSA or membrin as
indicated. (B) Quantitation of blots from panel B.
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Figure 16. Excess soluble rbet1 removes p115 from COPII vesicle membranes.
(A) Normal rat kidney (NRK) cells were transfected with myc‐VSV‐G DNA, infected
with vaccinia virus to drive over‐expression (see Methods), and incubated at 40oC to
allow the accumulation of myc‐VSV‐G in the ER. The cells were then permeabilized
at 40oC and incubated with rat liver cytosol in the presence of an ATP regeneration
system. Generated COPII vesicles were separated from cells by centrifugation. 0.3
μM of soluble rbet1 was added to the vesicles followed by an incubation of 1 hr.
Vesicles were then immunoisolated using the myc tag. The recombinant rbet1 used
in this experiment was dialyzed extensively in Buffer A. To eliminate any potential
effects caused by the buffer, similar amount of Buffer A was also added to the
vesicles as control. (B) Isolated vesicles were subjected to SDS‐PAGE and amounts of
p115 (top panel), cargo myc‐VSV‐G (middle panel), and vesicle membrane marker
p24 (bottom panel) were determined by immunoblotting. Vesicles generated by
untransfected NRK cells served as negative control; vesicles generated by myc‐VSV‐
G transfected cells without rbet1 or Buffer A addition served as positive control.
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Chapter IV. P115’s Role in SNARE Complex Assembly
The formation of a Sed5p/Sec22p/Betlp SNARE complex in yeast requires
the presence of the yeast p115 homologue Uso1p [96]. Also, p115 stimulates the
assembly of GOS‐28–syntaxin‐5 SNAREpin in vitro [116]. Since p115 bound to
monomeric SNAREs in our studies, we wondered whether this binding had a
detectable effect on SNARE complex assembly.
Soluble recombinant syntaxin 5, membrin, rbet1 and sec22b were incubated
on ice either in the presence or absence of p115 for four hours. Reaction mixtures
were gel‐filtered, and the fractions analyzed by immunoblotting. Quaternary SNARE
complexes are eluted from the gel filtration column in fractions 16, 17, 18 [29]. To
distinguish between the complete quaternary complex and ternary or binary SNARE
complexes whose elutions overlapped the same fractions, an antibody against the v‐
SNARE sec22b was used, for sec22b only enters into a SNARE complex when all
three of its cognate binding partners are present in a single complex [29]. As is
typical, only a small fraction of sec22b was incorporated into quaternary complexes.
Unexpectedly, we were not able to detect a stimulatory effect of p115 on the SNARE
assembly, though p115‐sec22b complexes were clearly present in fractions 8‐10
(Figure 17A).

One possibility that could explain the lack of stimulatory effects was that
p115 binding has a stabilizing effect on SNARE conformation rather than an
immediate catalytic effect. We therefore tried a different approach. Sec22b was pre‐
incubated overnight with or without p115, before the addition of other SNAREs.
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After a second incubation of four hours to allow the formation of SNARE complexes,
both reactions were passed through a gel filtration column and SNARE complexes
were quantified and compared. As shown in Figure 17B, the long pre‐incubation of
sec22b with p115 enhanced the formation of SNARE complex by at least two‐fold.
Adding rbet1 to the pre‐incubation mixture of sec22b and p115 did not cause any
additional enhancement of the complex formation (data not shown). Our findings
suggest that p115 may have a mild ‘chaperone’ effect on the SNAREs, possibly by
binding to the SNARE motif and keeping it in an optimal conformation for complex
assembly. This prediction does not necessarily contradict the catalyst model, for
p115 could still function as a SNARE catalyst downstream. Three caveats of this
purified experimental system that could also explain the lack of apparent catalytic
activity are the lack of cofactors required for p115's function, the lack of membrane
topological constraints, and the possibility that purified recombinant p115 was not
fully functional.
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Figure 17. P115 chaperone effect on SNARE complex assembly. (A)
Recombinant syntaxin 5, membrin, rbet1, and sec22b were incubated in the
presence or absence of 0.9 μM His6‐p115 for 4 hrs on ice. The reactions were passed
through a gel filtration column. Fractions were analyzed with SDS‐PAGE and
immunoblotting using anti‐sec22b antibody. The sec22b‐syntaxin 5‐membrin‐rbet1
complex elutes in fractions 16‐18. (B) P115 was incubated with sec22b overnight on
ice. The next day, other SNAREs were added to the reaction mixes and incubated for
4 hrs on ice. Reactions were then gel‐filtered and analyzed as described in (A). Top
panel in (B) represents the elution of a SNARE assembly reaction carried out in the
presence of a similar concentration of p115 but without any overnight pre‐
incubation between p115 and sec22b. The absence of a p115‐sec22b binary
complex in the top panel of (B) was likely due to relative short incubation time (4
hrs as opposed to overnight, as in the bottom panel). (C) Quantitation of A (left
panel) and B (right panel) fractions 6 through 26. Beyond fraction 26, the
chemiluminescence signal saturated the camera pixels and quantitative data was
not possible.
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Chapter V. Excess Recombinant P115 Inhibits P115 Function in vitro and
in vivo.
A. P115’s Effects on COPII Vesicle Tethering and Fusion in vitro
A requirement for p115 in COPII vesicle transport has been demonstrated
before [50, 99, 137], but the precise steps at which p115 is involved in the tethering
and fusion of COPII vesicles has not been resolved. We have developed in vitro
assays of COPII vesicle tethering and fusion in which two distinctly labeled,
fusogenic COPII vesicle populations are generated from permeabilized normal rat
kidney (NRK) cells, one carrying the myc tag, the other radiolabeled by 35S [3, 52].
Notably, if the two vesicle populations are co‐incubated at 32°C, fusion of the
differently labeled vesicles results in a heterotrimer containing both a myc‐labeled
VSV‐G subunit and a 35S labeled VSV‐G* subunit, due to the dynamic equilibrium
between VSV‐G trimers and monomers [126]. To detect fusion, the mixtures are
detergent‐solubilized and VSV trimers are immunoprecipitated using the myc tag. In
this protocol, fusion is a function of the 35S labeled VSV‐G trimers present in the
solubilized vesicles. To detect tethering, the two populations of COPII vesicles are
incubated together at 32°C and immuno‐isolated intact without solubilization using
anti‐myc antibody beads. The beads are then analyzed by SDS‐PAGE and
autoradiography for the presence of 35S‐VSV‐G, which represents co‐isolated,
physically associated vesicles.
To test p115’s effects on vesicle fusion, we first generated a p115‐free cytosol
to use in the assay. Rat liver cytosol was incubated with a p115 antibody before
depletion with fixed S. aureus cells. The depletion of p115 was complete as shown in
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Figure 18A, top left panel. Amounts of several known p115‐interacting partners
were also analyzed by Western. With the exception of GM130, none were affected.
GM130 is a primarily Golgi‐localized tether and was implicated to function at a later
step in ER‐Golgi anterograde transport independently of p115 [138]. There has
been no evidence suggesting GM130 may affect homotypic COPII vesicle fusion.
Thus we did not expect a partial co‐depletion of GM130 to have a significant effect
on the COPII vesicle tethering/fusion assay. A ‘mock’ cytosol treated with non‐
immune rabbit IgG was used as control.
To test the functional effects of p115 depletion and the back‐addition of
recombinant p115, myc‐VSV‐G vesicles and 35S‐VSV‐G vesicles were mixed and
incubated in either p115‐free cytosol or mock‐treated cytosol, with or without
additional purified recombinant p115, and fusion was monitored. Fusion levels
were normalized to the level in untreated RLC. Depletion of p115 reduced vesicle
fusion by 70% of mock (Figure 18C, red versus blue curves at zero point on x‐axis).
This extends previous antibody inhibition studies [52] implying that p115 is
required at the first fusion step in the secretory pathway, leading to VTC biogenesis.
Recombinant p115 failed to restore fusion activity, although we observed a small
stimulation at a concentration of 0.1 μM (Figure 18C, red curve). The reasons for the
lack of rescue are not clear. It is possible that the optimal dose range for p115’s
function is very narrow (see Discussion), and we were not able to pinpoint the
concentration at which sufficient p115 is provided yet the ratio and/or access of
p115 to its cofactors (e.g. Rab1) is close to physiological. Surprisingly, though,
recombinant p115 seemed to have a strong inhibitory effect on vesicle fusion when
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added in excess to the endogenous protein in mock‐depleted cytosol (Figure 18C,
blue curve). The p115 preparation employed in these studies was the Ni‐NTA
fraction shown in Figure 18B.
We wanted to understand the unexpected inhibitory effect of wild type
recombinant p115. To eliminate the possibility that a truncated, dominant‐negative
form of p115 was present in the protein preparation, we further purified the Ni‐NTA
enriched p115 with Mono Q anion exchange chromatography (Figure 18B, also see
Materials and Methods). Although many partial products were removed by the
additional step, the purified fraction still contained a low molecular weight
degradation/truncation fragment of p115. Since we were unable to prepare the full‐
length protein without this contaminant, we purified the small fragment to near‐
homogeneity by velocity sedimentation (Figure 18B, third lane) and used it as a
control in subsequent experiments. When titrated in the presence of untreated
cytosol, the Mono Q‐purified full‐length p115 inhibits both fusion (Figure 18D) and
tethering (Figure 18E) of COPII vesicles in a dose dependent manner. Neither buffer
control nor the p115 small fragment had any effects on fusion or tethering activities.
Thus, inhibitory activity appears to reside with the full‐length protein. We observed
a small stimulation of vesicle tethering by recombinant p115 in low excesses (0.002
μM, Figure 18E). This effect was not present in the fusion experiment (Figure 18D).
On the other hand, we noted that compared to the tethering assay, the fusion assay
required lower concentrations of excess p115 to reach the maximum inhibitory
effect. It is possible that the fusion of vesicles is more sensitive to changes in p115
concentration than vesicle tethering. In summary, recombinant full‐length p115 had
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very slight stimulatory effects at very low concentrations that were overcome by
potent inhibitory activity in both the presence and absence of endogenous p115.

B. Excess P115’s Effects on the Secretory Pathway in vivo
To test whether excess p115 also inhibited p115 trafficking function in vivo,
we over‐expressed full‐length, functional p115 in HeLa cells. As shown in Figure
19A‐C, overexpression of a myc‐tagged p115 construct in vivo causes disruption of
HeLa cell Golgi structure monitored with GM130 labeling. Golgi disruption clearly
correlated with p115 expression level, since moderately expressing cells displayed
morphologically normal Golgis. We know that the myc‐tagged construct was
intrinsically functional, since when expressed at moderate levels it restored the
normal GM130 pattern to p115‐depleted cells with otherwise dispersed Golgis
(Figure 19D‐F). Phenotypes of siRNA depletion of p115 in HeLa cells have been
characterized earlier [114].
It would appear that p115 has a tight functional dose range. A certain level of
p115 is required for COPII vesicle tethering and fusion, yet these events are
inhibited when the tether is present in excess. These findings are in line with our
SNARE‐binding results, which suggest that p115 needs to be removed from SNARE
complexes prior to their completion. One would expect that excess p115 might
inhibit SNARE‐mediated fusion by slowing down or preventing this removal
process.
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Figure 18. Recombinant fulllength p115 inhibits in vitro COPII vesicle
tethering and fusion. (A) Depletion of p115 from rat liver cytosol. Rat liver cytosol
was treated with rabbit anti‐p115 antibody (p115 dpl.), or purified rabbit IgG
(Mock) for 2 hrs on ice, and depleted with fixed S. aureus cells for 15 min. (Ctrl.)
represents RLC without any treatment. Amounts of p115, GM130, sec23, beta‐COP,
sec31, and GBF1 were analyzed after depletion. (B) Ni‐NTA purified recombinant
His6‐tagged p115 (left lane) was further purified on a Mono Q column (middle lane).
The small truncation fragment of p115 was purified from the full‐length protein
preparation by velocity sedimentation (right lane). (C) Both p115 depletion and
recombinant p115 addition inhibits in vitro COPII vesicle fusion. Myc‐tagged and
35S‐tagged VSV‐G COPII vesicles were incubated together at 32oC for 1 hr, either in
the presence of mock‐depleted cytosol (blue curve) or p115‐depleted cytosol (red
curve), and the indicated concentrations of recombinant p115 ranging from 0.1‐1
μM (x‐axis) was added to the reactions. After adding Triton X‐100, VSV‐G trimers
were immunoprecipitated using the myc tag and heterotrimers containing 35S were
quantitated as a measure of fusion. Fusion was normalized to percentage of the
positive control reaction in which untreated RLC was used and no additional protein
was added. Ice control (green) indicates fusion reactions incubated on ice. Data
points at zero p115 concentration are representative of triplicate reactions, with
error bars representing S. D. The remaining data points were obtained from
singlicate reactions. The experiment was repeated three times with qualitatively
similar outcomes. (D) COPII vesicle fusion in the presence or absence of
recombinant Mono Q purified p115. Myc‐tagged and 35S‐tagged VSV‐G COPII vesicles
were incubated together at 32°C for 1 hr in the presence of untreated RLC with
normal level of endogenous p115 and the indicated concentrations of Mono Q p115
(red curve) or p115 small fragment (green curve) ranging from 0.002‐0.09 μM.
Triton X‐100 was added to the reactions and VSV‐G heterotrimers were
immunoprecipitated and quantitated as described above. Due to the high KCl
content of the Mono Q column elution buffer, we also tested Mono Q elution buffer
(blue curve). Fusion was normalized to percentage of the buffer control with no
additional p115. The no‐bio control represents signal obtained from pellets isolated
with non‐biotinylated myc antibody. Data points are duplicates, with error bars
representing S.E.M. The asterisk marks a control data point that resulted in p=.027
in a two‐tailed T‐test with the corresponding full‐length p115 data point. (E) COPII
vesicle tethering in the presence or absence of recombinant p115. Myc‐tagged and
35S‐tagged VSV‐G COPII vesicles were incubated together at 32°C for 1 hr with
untreated RLC and the indicated concentrations of Mono Q purified p115 (red
curve), p115 small fragment (green curve), or Mono Q buffer control (blue curve).
Intact vesicles were immunoisolated in the absence of detergent using the myc tag
and recovered 35S‐VSV‐G quantitated as a measure of tethering. Tethering was
normalized to percentage of the buffer control with no additional p115. Data points
at 0.002 μM protein concentration were obtained from quadruplicate reactions,
other data points are representative of duplicates. Error bars represent S.E.M. The
experiments in D and E were repeated twice with similar outcomes.
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Figure 19. Effects of fulllength myctagged p115 in vivo. HeLa cells
overexpressing myc‐p115 labeled with anti‐myc antibodies (A) displayed disrupted
Golgi morphology, as indicated by labeling of the Golgi marker GM130 (B). The same
myc‐p115 construct, when expressed at moderate levels in p115‐knockdown cells
(D), rescued the Golgi fragmentation phenotype caused by p115 depletion, as
indicated by GM130 labeling (E). This experiment was performed by Robert Grabski
at the University of Alabama, Birmingham.
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Chapter VI. Binding Properties of a Functional, Endogenous Rat Liver
P115 Recapitulate Purified Recombinant P115
We wanted to validate the most important conclusions from purified SNARE
binding studies in Figures 12‐16 using functionally robust, endogenous p115. A
partially purified liver p115 could potentially provide optimal functional intactness
and yet also likely reflect the intrinsic binding properties of p115. Toward this end,
we prepared rat p115 at three increasing levels of enrichment. First was crude NRK
cytosol from cells expressing rat his‐p115 (referred to as “NRK cytosol”;
immunnoblot analysis not shown). Second was endogenous rat liver p115 purified
by ammonium sulfate fractionation and Superdex 200 chromatography (referred to
as “rat liver Superdex”), enriched approximately 18‐fold relative to crude rat liver
cytosol. This fraction is characterized by immunoblotting in Figure 20D. Third was
endogenous rat liver p115 purified by several conventional chromatography steps
to yield a simplified protein pattern with p115 representing a major band (referred
to as “rat liver Mono Q”). This fraction is characterized by Coommassie gel in Figure
20B, left panel. Next we evaluated whether rat p115 at different purity levels would
behave similarly in SNARE bead binding assays. As shown in Figure 20A and B,
when tested at a limiting concentration, “NRK cytosol” p115 and “rat liver Mono Q”
p115 bound specifically to SNARE beads with similar characteristics‐‐weak binding
to membrin and strong binding to rbet1, as observed in Figure 13 with purified
recombinant His‐p115 expressed in bacteria. SNAREs immobilized on the beads are
characterized by Coommassie gel in Figure 20B, right panel.
Given the apparent robustness of the SNARE bead binding assay with regard to

70

p115 purity, we chose to confirm and extend our main conclusion, that p115 prefers
to bind SNARE monomers and not complexes, using the endogenous rat liver
Superdex fraction, since it represented a compromise between biochemical purity
and likely functional intactness. Importantly, when tested in an ER‐to‐Golgi
transport reconstitution in semi‐intact NRK cells [127], the Superdex p115 fully
reconstituted transport activity to p115‐depleted cytosol, indicating that it was
functionally intact (Figure 20C, solid circles). This was important since we found
that further purified p115 preparations from various sources only partially restored
activity and/or lost activity readily (not shown), perhaps due to the lack of cofactors
or stabilizing interactions. The p115 in the Superdex fraction was required for the
reconstituting activity, as opposed to other rate‐limiting factors, since p115
antibody depletion blocked the reconstitution (Figure 20C, open circles).
To test whether the rat liver p115 bound to SNAREs but not SNARE
complexes, we prepared GST‐rbet1 beads, GST‐membrin beads, and beads that
contained a stoichiometric complex of GST‐membrin and rbet1 (Figure 20E. The
Superdex p115 fraction was incubated with each of the beads and unbound or
loosely bound proteins were removed by washing. As shown in Figure 20F, the p115
bound most strongly to the rbet1 beads, but at the concentration tested also
significantly interacted with membrin beads. Strikingly, no specific binding was
detected to the membrin•rbet1 beads, despite the presence of stoichiometric
amounts of two proteins it interacted with separately. The rbet1 preparation on
these beads was identical to the soluble rbet1 used for Figures 12 and 14, which
bound p115 very well. Additionally, the membrin and rbet1 employed in the binary
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complex were fully capable of forming higher order complexes, since together they
exhibited potentiated binding with soluble syntaxin 5, indicating formation of a
ternary SNARE complex (Figure 20G) [29]. In conclusion, functionally intact
endogenous rat liver p115 bound to individual SNAREs but not SNARE complexes,
extending and validating the conclusions from purified recombinant proteins.
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Figure 20. Binding properties of endogenous rat liver p115. (A) GST, GST‐
rbet1, or GST‐membrin were immobilized on glutathione‐Sepharose beads. Beads
were incubated with crude or partially purified fractions, “NRK cytosol” and “rat
liver MonoQ”, respectively, such that the final p115 concentration was
approximately 20 nM by Western blot. After binding and washing reactions
similarly to as in Figure 3, the bead‐bound p115 was determined by Western blots
and quantitated. (B) Coommassie‐stained gels showing the Mono Q p115
preparation used in the binding experiment with a rat his‐p115 standard (left
panel) and the proteins on each type of beads at the concentration employed (right
panel). (C) ER‐to‐Golgi transport reconstitution in semi‐intact NRK cells, where VSV‐
G transport is indicated by conversion of VSV G cargo from the endoglycosidase H‐
sensitive to –resistant form. The partially purified rat liver Superdex fraction fully
reconstituted the assay in the presence of p115‐depleted cytosol (closed circles);
the Superdex fraction lost its restorative activity when it was depleted with anti‐
p115 (open circles). (D) Immunoblot analysis of the Superdex fraction, with or
without immunodepletion, relative to the starting cytosol and ammonium sulfate
cut, and equal protein loading in each lane. Blotting for other species demonstrates
selectivity in the purification; rsly1 shows an overall lack of enrichment over the
two‐step purification, while a 55 kD degradation/truncation product of p115 visible
in cytosol on over‐exposed blots was removed during the purification. (E)
Coommassie–stained gel documenting proteins on the beads for binding studies in
part (F) and (G). Stoichiometry of the membrin and rbet1 bands indicated on the
gels on the membrin+rbet1 beads was calculated by quantitation relative to BSA
standards. (F) Rat liver Superdex fraction was incubated with the beads shown in
(E) at approximately 30 nM p115, then unbound p115 was removed by washing and
bound p115 determined by Western blotting and quantitation. The graph shows
beads used along the bottom and bound p115 on the y‐axis. (G) Membrin beads and
soluble rbet1 can form a potentiated ternary SNARE complex. Presence of different
beads and soluble proteins are indicated below and syntaxin 5 binding is shown on
the y axis. Error bars represent standard error of duplicate determinations. (H)
Excess Superdex p115 inhibits in vitro ER‐Golgi transport.
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Chapter VII. Discussion
A. P115’s SNARE Binding Preferences in vitro
Using a gel filtration assay, we have for the first time provided direct
evidence that p115 preferentially interacts with monomeric SNARE motifs. Our
results demonstrated that p115 binds mammalian ER‐Golgi v‐SNARE sec22b and t‐
SNARE rbet1. The fact that p115 can interact with the ΔTM recombinant rbet1 led
us to believe that the SNARE motif is the binding site for p115. Further studies with
the N‐terminal longin domain of sec22b showed that p115 does not interact with
this region, suggesting that the SNARE motif accounts for the interactions between
p115 and the recombinant ΔTM sec22b. Structural similarities between p115’s
coiled‐coil domain and the SNARE motif suggest that they could form a coiled‐coil
structure.
It was unexpected that our solution binding method did not detect p115‐
membrin or p115‐syntaxin 5 interactions, which have been demonstrated before
using other methods. One possibility is that the highly oligomeric state of syntaxin 5
and membrin blocked p115’s access to the SNARE motif. Due to lower affinity
binding, p115’s interactions with these SNAREs may be transient, and the resulting
complexes would be too unstable to be detected by the gel filtration assay.
Since SNARE motifs are the binding sites for p115, and since these motifs are
joined into a four‐helix‐bundle during fusion, p115 might have to dissociate from its
bound partner during the formation of a SNARE complex. In support of this
hypothesis, our results showed that p115 interacts with rbet1 alone, but not SNARE
complexes containing rbet1. In addition, membrin is able to displace p115 from a
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pre‐formed rbet1‐p115 complex. Furthermore, in vitro studies show that soluble
monomeric rbet1 can compete p115 off COPII vesicles, suggesting a free monomeric
SNARE motif is a major binding site for p115 on membrane.
We have also demonstrated that excess p115 inhibits COPII vesicle tethering
and fusion in vitro and Golgi homeostasis in vivo. These findings are consistent with
our binding studies, from which we have concluded that p115 needs to dissociate
from SNARE complexes before their formation is complete. Excess p115 could
potentially impair fusion efficiency by slowing down this removal process.
However, it is worth noting that the inhibitory effect of p115 on vesicle fusion has
not been observed in previous studies using in vitro systems. p115 purified from rat
liver showed no inhibitory effects on the transport of VSV‐G to the medial Golgi at
160% of cytosolic level [99], and recombinant bovine p115 purified from insect cells
showed no such effects on VSV‐G processing at high concentrations, either [50]. One
potential explanation for the apparent discrepancy is that our assay specifically
measures the homotypic fusion aspect of the VSV‐G transport pathway, and employs
vesicles in very dilute suspension; this could make it more sensitive to changes in
p115 on‐off dynamics than a more intact subcellular reconstitution containing local
concentration gradients of cofactors and a cytoskeleton. In our hands the in vitro
ER‐to‐Golgi assay was also inhibited by excess p115, but at concentrations
exceeding those that inhibited in the vesicle fusion assay. Both assays contained
about 30 nM of rat liver cytosolic p115 under normal conditions. Addition of an
additional 20 nM of purified recombinant p115 inhibited the fusion assay
(representing ~166% of cytosolic, Figure 18D) whereas inhibition of the ER‐to‐

76

Golgi transport assay didn’t occur until addition of an additional 60 nM of Superdex
p115 (representing ~300% of cytosolic, Figure 20H). Fully purified p115 also
inhibited the ER‐to‐Golgi assay, but to a much lesser degree than in the fusion assay.
We believe that the fusion assay helped reveal an inhibitory activity of excess p115
not apparent until higher concentrations in other systems.
We did not see as high a level of stimulation by p115 on SNARE complex
formation as was observed in previous studies performed with Golgi detergent
extract [116]. Many factors could have contributed to this difference. First, our
binding studies were carried out with purified proteins as opposed to Golgi extracts.
It is possible that certain p115 accessory factors and/or SNARE destabilizing factors
are absent in the purified system, resulting in p115 appearing to lose some SNARE
assembly function. Another factor is that the embedding of SNAREs in a membrane
is important for p115’s catalytic action. We did notice, however, that with the
addition of p115, the elution of some monomer rbet1 shifted from fractions 32‐34 to
fractions 26‐32 (Figure 12B), suggesting that the SNARE might have undergone
conformational changes in the presence of p115. Furthermore, whereas p115
appears to have no instantaneous effect on the formation of SNARE complexes, its
pre‐incubation with sec22b increases the complex yield by 2~3 fold (Figure 17B).
This increase is more or less in agreement with p115’s published effects on purified
syntaxin 5‐GOS‐28 complex formation [116]. Based on the evidence, we suspect that
instead of a SNARE catalyst, p115 may act as a SNARE chaperone by modifying the
SNARE motifs and/or keeping them in an optimal conformation, at least in soluble
SNARE assembly reactions. Whether p115 also assembles SNAREs catalytically
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when embedded in membranes remains to be experimentally addressed.

B. Model of P115’s Mechanism of Action
Taken together, our results support a model in which p115 binds monomeric
SNAREs on the membrane to stabilize their conformation and possibly facilitate
fusion by catalyzing SNARE‐SNARE interactions, and then is displaced as the
SNAREs come together. This potential mechanism of action would explain the
observed inhibition of trafficking by excess p115 in vitro and in vivo. For a
monomeric SNARE, the binding of p115 and the binding of another SNARE could be
mutually exclusive, and excess p115 would slow down p115’s removal from the
forming SNARE complex. The model also provides insights into the observed highly
dynamic state of membrane‐bound p115 [100] that could indicate synchronization
between p115 recruitment/dissociation and the fusion process.
A possible model for molecular events during p115‐mediated docking and
fusion of vesicles is that p115 is recruited to the membrane by the dimer’s globular
head and/or CC1 domains via binding to Rab1 or SNAREs (Figure 21A). P115 could
then use a free SNARE‐interacting domain (either CC1 or CC4) or the head domain
to initiate interactions with SNAREs or Rab1 on the opposing membrane (green
arrows), thus tethering the vesicles together. Subsequently, p115 could align the
SNAREs on juxtaposed membranes by conformational changes within the p115
molecule. It is also possible that p115 never directly bridges the two membranes,
but works solely on the vesicle membrane to enhance the efficiency of SNARE
assembly by maintaining their reactivity and concentrating monomeric SNAREs at
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fusion sites where Rab1 is active (Figure 21B). This would make p115 less of a
traditional ‘tether’, and more of a chaperone and/or catalyst for SNARE‐mediated
fusion. Further studies will be essential to define the details of molecular tethering
and SNARE coupling by p115.

C. Significance to the Field
Despite the important role of tethers in fusion, a lot remains unknown about
their working mechanisms [54, 65]. The recently solved crystal structure of Dsl1
complex provides perhaps the first detailed view of the function of a tether on a
molecular basis [70], and parallels have been drawn between Dsl1 and other MTCs
in the CATCHR family that have similar interactions with SNAREs [68, 139, 140].
The presence of the homologous SNARE‐interacting MUN domain, for example,
suggests a shared SNARE‐related function [142, 143]. However, it is still unclear
how the recruitment of Dsl1 is regulated without an interacting Rab [74], and no
coat component that interacts with exocyst has been identified [49]. Despite the
extensively characterized interactions between MTCs and other trafficking‐related
proteins, the functional relevance of these interactions are not all known, and a clear
picture of the coordinated collaboration between Rabs, tethers, coats, and SNAREs is
yet to emerge.
Comparing to the MTCs, rod‐like tethering factors are relatively
understudied, and their interactions with other trafficking components, in particular
the SNARE proteins, are less defined [49 and Table 1]. It is unclear whether Golgins
function as bona fide tethers by assembling membrane‐bridging complexes, or
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facilitate vesicle tethering and fusion through other means (e. g. by acting as SNARE
catalysts), and the two possibilities are not mutually exclusive. Rod‐like tethers, too,
display strong structural homologies such as globular head domains with Rab
binding sites, and predominant, elongated coil‐coils with multiple flexible ‘hinge’
regions [53, 54]. Aside from p115, other SNARE interactions have been reported for
Golgins. GM130, for example, has been shown to bind Syntaxin 5 and regulate its
SNARE activity [84], and tether GCC185 interacts with syntaxin 16 [141]. It is
therefore possible that this group of tethers interact with SNAREs in a similar
manner as p115 and share a similar mode of action.
We hope our characterization of p115‐SNARE interactions leads to a better
understanding of p115 mechanism of action, as well as providing new insights into
the general functions of Golgin tethers and their role in the secretory pathway. In
this study we provide evidence for a potential novel model of action for the tether
protein p115, in which p115 binds monomeric SNAREs on the membrane, possibly
facilitates fusion by catalyzing SNARE‐SNARE interactions, and then is displaced as
the SNAREs come together. The fact that p115 binds the SNARE motif through two
SNARE homologous domains suggests that these bindings have some of the
properties of SNARE‐SNARE interactions, and the CC1‐ or CC4‐SNARE complex may
structurally resemble a partial SNARE bundle. Through these interactions p115
might stabilize the SNARE motif in a partially structured conformation and prime it
for more efficient assembly into a SNARE complex. A more detailed structural
analysis of the p115‐rbet1 complex might reveal more insights into p115’s SNARE‐
related function.
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Figure 21. Possible mechanisms of action of p115. (A) Two membrane‐bridging
models for p115. P115 dimer (green) is recruited to membranes by interacting with
monomeric SNAREs (yellow and red, gray and cyan) through the CC1 and/or CC4
domains, and/or by binding to Rab1 (dark blue) through the globular head domain.
In the upper version, p115 also binds a monomeric SNARE on an opposing
membrane using its free CC4 domain. The binding of p115’s globular head domain
to Rab1 on the same or opposing membrane causes a conformational change in the
tail region of p115, which shortens the distance between membranes and places the
N‐termini of the SNARE motifs in close proximity. The formation of the four‐helix
bundle expels p115. (B) P115 dimer captures and concentrates the SNAREs on the
same membrane (yellow and cyan) using both the CC1 and CC4 domains.
Conformational changes bring the juxtaposed SNAREs together, as well as prime
them to interact with SNAREs on the opposing membrane. Our data does not
distinguish between the displayed scenarios and several similar variations. The
cartoon representation of p115 was adapted from the p115 structure with the acidic
C‐terminus omitted (106).

81

References
1.
Martinez‐Menarguez JA, Geuze HJ, Slot JW, Klumperman J. Vesicular tubular
clusters between the ER and Golgi mediate concentration of soluble secretory
proteins by exclusion front COPI‐coated vesicles. Cell 1999;98(1):81‐90.
2.
Martoglio B, Dobberstein B. Signal sequences: more than just greasy
peptides. Trends in Cell Biology 1998;8(10):410‐415.
3.
Xu DL, Hay JC. Reconstitution of COPII vesicle fusion to generate a pre‐Golgi
intermediate compartment. Journal of Cell Biology 2004;167(6):997‐1003.
4.
Bonifacino JS, Lippincott‐Schwartz J. Opinion ‐ Coat proteins: shaping
membrane transport. Nature Reviews Molecular Cell Biology 2003;4(5):409‐414.
5.
Lee C, Goldberg J. Structure of Coatomer Cage Proteins and the Relationship
among COPI, COPII, and Clathrin Vesicle Coats. Cell 2010;142(1):123‐132.
6.
Cosson P, Letourneur F. Coatomer (COPI)‐coated vesicles: role in
intracellular transport and protein sorting. Current Opinion in Cell Biology
1997;9(4):484‐487.
7.
Lee MCS, Miller EA. Molecular mechanisms of COPII vesicle formation.
Seminars in Cell & Developmental Biology 2007;18(4):424‐434.
8.
Hughes H, Stephens DJ. Assembly, organization, and function of the COPII
coat. Histochemistry and Cell Biology 2008;129(2):129‐151.
9.
Edeling MA, Smith C, Owen D. Life of a clathrin coat: insights from clathrin
and AP structures. Nature Reviews Molecular Cell Biology 2006;7(1):32‐44.
10.
Pearse BM. Clathrin: a unique protein associated with intracellular transfer
of membrane by coated vesicles. Proc Natl Acad Sci U S A 1976;73(4):1255‐1259.
11.
Brodsky FM, Chen CY, Knuehl C, Towler MC, Wakeham DE. Biological basket
weaving: formation and function of clathrin‐coated vesicles. Annu Rev Cell Dev Biol
2001;17:517‐568.
12.
Ungar D, Hughson FM. SNARE protein structure and function. Annu Rev Cell
Dev Biol 2003;19:493‐517.
13.
Sutton RB, Fasshauer D, Jahn R, Brunger AT. Crystal structure of a SNARE
complex involved in synaptic exocytosis at 2.4 A resolution. Nature
1998;395(6700):347‐353.

82

14.
Sorensen JB, Wiederhold K, Muller EM, Milosevic I, Nagy G, de Groot BL,
Grubmuller H, Fasshauer D. Sequential N‐ to C‐terminal SNARE complex assembly
drives priming and fusion of secretory vesicles. EMBO J 2006;25(5):955‐966.
15.
Hanson PI, Heuser JE, Jahn R. Neurotransmitter release ‐ four years of SNARE
complexes. Curr Opin Neurobiol 1997;7(3):310‐315.
16.
Fasshauer D, Margittai M. A transient N‐terminal interaction of SNAP‐25 and
syntaxin nucleates SNARE assembly. J Biol Chem 2004;279(9):7613‐7621.
17.
Antonin W, Fasshauer D, Becker S, Jahn R, Schneider TR. Crystal structure of
the endosomal SNARE complex reveals common structural principles of all SNAREs.
Nat Struct Biol 2002;9(2):107‐111.
18.
Fasshauer D, Sutton RB, Brunger AT, Jahn R. Conserved structural features of
the synaptic fusion complex: SNARE proteins reclassified as Q‐ and R‐SNAREs. Proc
Natl Acad Sci U S A 1998;95(26):15781‐15786.
19.
May AP, Whiteheart SW, Weis WI. Unraveling the mechanism of the vesicle
transport ATPase NSF, the N‐ethylmaleimide‐sensitive factor. J Biol Chem
2001;276(25):21991‐21994.
20.
Sollner T, Bennett MK, Whiteheart SW, Scheller RH, Rothman JE. A protein
assembly‐disassembly pathway in vitro that may correspond to sequential steps of
synaptic vesicle docking, activation, and fusion. Cell 1993;75(3):409‐418.
21.
Sudhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM
proteins. Science 2009;323(5913):474‐477.
22.
Misura KM, Scheller RH, Weis WI. Three‐dimensional structure of the
neuronal‐Sec1‐syntaxin 1a complex. Nature 2000;404(6776):355‐362.
23.

Munson M. To protect or reject. Elife;3:e03374.

24.
Lobingier BT, Nickerson DP, Lo SY, Merz AJ. SM proteins Sly1 and Vps33 co‐
assemble with Sec17 and SNARE complexes to oppose SNARE disassembly by Sec18.
Elife;3:e02272.
25.
Starai VJ, Hickey CM, Wickner W. HOPS proofreads the trans‐SNARE complex
for yeast vacuole fusion. Mol Biol Cell 2008;19(6):2500‐2508.
26.
Fernandez I, Ubach J, Dulubova I, Zhang X, Sudhof TC, Rizo J. Three‐
dimensional structure of an evolutionarily conserved N‐terminal domain of syntaxin
1A. Cell 1998;94(6):841‐849.

83

27.
Bennett MK, Garcia‐Arraras JE, Elferink LA, Peterson K, Fleming AM, Hazuka
CD, Scheller RH. The syntaxin family of vesicular transport receptors. Cell
1993;74(5):863‐873.
28.
Misura KM, Bock JB, Gonzalez LC, Jr., Scheller RH, Weis WI. Three‐
dimensional structure of the amino‐terminal domain of syntaxin 6, a SNAP‐25 C
homolog. Proc Natl Acad Sci U S A 2002;99(14):9184‐9189.
29.
Xu D, Joglekar AP, Williams AL, Hay JC. Subunit structure of a mammalian
ER/Golgi SNARE complex. J Biol Chem 2000;275(50):39631‐39639.
30.
Nicholson KL, Munson M, Miller RB, Filip TJ, Fairman R, Hughson FM.
Regulation of SNARE complex assembly by an N‐terminal domain of the t‐SNARE
Sso1p. Nat Struct Biol 1998;5(9):793‐802.
31.
Parlati F, Weber T, McNew JA, Westermann B, Sollner TH, Rothman JE. Rapid
and efficient fusion of phospholipid vesicles by the alpha‐helical core of a SNARE
complex in the absence of an N‐terminal regulatory domain. Proc Natl Acad Sci U S A
1999;96(22):12565‐12570.
32.
Gonzalez LC, Jr., Weis WI, Scheller RH. A novel snare N‐terminal domain
revealed by the crystal structure of Sec22b. J Biol Chem 2001;276(26):24203‐
24211.
33.
Uemura T, Sato MH, Takeyasu K. The longin domain regulates subcellular
targeting of VAMP7 in Arabidopsis thaliana. FEBS Lett 2005;579(13):2842‐2846.
34.
Hasegawa H, Zinsser S, Rhee Y, Vik‐Mo EO, Davanger S, Hay JC. Mammalian
Ykt6 is a neuronal SNARE targeted to a specialized compartment by its profilin‐like
amino terminal domain. Molecular Biology of the Cell 2003;14(2):698‐720.
35.
Fukasawa M, Varlamov O, Eng WS, Sollner TH, Rothman JE. Localization and
activity of the SNARE Ykt6 determined by its regulatory domain and palmitoylation.
Proc Natl Acad Sci U S A 2004;101(14):4815‐4820.
36.
Liu YT, Flanagan JJ, Barlowe C. Sec22p export from the endoplasmic
reticulum is independent of SNARE pairing. Journal of Biological Chemistry
2004;279(26):27225‐27232.
37.
Mancias JD, Goldberg J. The transport signal on Sec22 for packaging into
COPII‐coated vesicles is a conformational epitope. Mol Cell 2007;26(3):403‐414.
38.
Ayong L, Raghavan A, Schneider TG, Taraschi TF, Fidock DA, Chakrabarti D.
The Longin Domain Regulates the Steady‐State Dynamics of Sec22 in Plasmodium
falciparum. Eukaryotic Cell 2009;8(9):1330‐1340.

84

39.
Wen W, Chen L, Wu H, Sun X, Zhang M, Banfield DK. Identification of the yeast
R‐SNARE Nyv1p as a novel longin domain‐containing protein. Mol Biol Cell
2006;17(10):4282‐4299.
40.
Weber T, Zemelman BV, McNew JA, Westermann B, Gmachl M, Parlati F,
Sollner TH, Rothman JE. SNAREpins: minimal machinery for membrane fusion. Cell
1998;92(6):759‐772.
41.
Fasshauer D, Antonin W, Subramaniam V, Jahn R. SNARE assembly and
disassembly exhibit a pronounced hysteresis. Nat Struct Biol 2002;9(2):144‐151.
42.
Laufman O, Hong W, Lev S. The COG complex interacts with multiple Golgi
SNAREs and enhances fusogenic assembly of SNARE complexes. J Cell Sci;126(Pt
6):1506‐1516.
43.
McNew JA, Parlati F, Fukuda R, Johnston RJ, Paz K, Paumet F, Sollner TH,
Rothman JE. Compartmental specificity of cellular membrane fusion encoded in
SNARE proteins. Nature 2000;407(6801):153‐159.
44.
Parlati F, McNew JA, Fukuda R, Miller R, Sollner TH, Rothman JE. Topological
restriction of SNARE‐dependent membrane fusion. Nature 2000;407(6801):194‐
198.
45.
Fasshauer D, Antonin W, Margittai M, Pabst S, Jahn R. Mixed and non‐cognate
SNARE complexes. Characterization of assembly and biophysical properties. J Biol
Chem 1999;274(22):15440‐15446.
46.
Trahey M, Hay JC. Transport vesicle uncoating: it's later than you think.
F1000 Biol Rep;2:47.
47.
Cai H, Yu S, Menon S, Cai Y, Lazarova D, Fu C, Reinisch K, Hay JC, Ferro‐Novick
S. TRAPPI tethers COPII vesicles by binding the coat subunit Sec23. Nature
2007;445(7130):941‐944.
48.
Whyte JR, Munro S. Vesicle tethering complexes in membrane traffic. J Cell Sci
2002;115(Pt 13):2627‐2637.
49.
Sztul E, Lupashin V. Role of vesicle tethering factors in the ER‐Golgi
membrane traffic. FEBS Lett 2009;583(23):3770‐3783.
50.
Allan BB, Moyer BD, Balch WE. Rab1 recruitment of p115 into a cis‐SNARE
complex: programming budding COPII vesicles for fusion. Science
2000;289(5478):444‐448.

85

51.
Guo W, Roth D, Walch‐Solimena C, Novick P. The exocyst is an effector for
Sec4p, targeting secretory vesicles to sites of exocytosis. Embo Journal
1999;18(4):1071‐1080.
52.
Bentley M, Liang Y, Mullen K, Xu D, Sztul E, Hay JC. SNARE status regulates
tether recruitment and function in homotypic COPII vesicle fusion. J Biol Chem
2006;281(50):38825‐38833.
53.
Chan EKL, Fritzler MJ. Golgins: coiled‐coil‐rich proteins associated with the
Golgi Complex. Electronic Journal of Biotechnology 1998; 1(2):1‐10.
54.
Lupashin V, Sztul E. Golgi tethering factors. Biochimica Et Biophysica Acta‐
Molecular Cell Research 2005;1744(3):325‐339.
55.
Orci L, Perrelet A, Rothman JE. Vesicles on strings: Morphological evidence
for processive transport within the Golgi stack. Proceedings of the National
Academy of Sciences of the United States of America 1998;95(5):2279‐2283.
56.
Waters MG, Clary DO, Rothman JE. A Novel 115‐Kd Peripheral Membrane‐
Protein Is Required for Intercisternal Transport in the Golgi Stack. Journal of Cell
Biology 1992;118(5):1015‐1026.
57.
Shorter J, Warren G. A role for the vesicle tethering protein, p115, in the post‐
mitotic stacking of reassembling Golgi cisternae in a cell‐free system. Journal of Cell
Biology 1999;146(1):57‐70.
58.
Nakamura N, Rabouille C, Watson R, Nilsson T, Hui N, Slusarewicz P, Kreis TE,
Warren G. Characterization of a cis‐Golgi matrix protein, GM130. Journal of Cell
Biology 1995;131(6):1715‐1726.
59.
Barr FA, Nakamura N, Warren G. Mapping the interaction between GRASP65
and GM130, components of a protein complex involved in the stacking of Golgi
cisternae. Embo Journal 1998;17(12):3258‐3268.
60.
Sonnichsen B, Lowe M, Levine T, Jamsa E, Dirac‐Svejstrup B, Warren G. A role
for giantin in docking COPI vesicles to Golgi membranes. J Cell Biol
1998;140(5):1013‐1021.
61.
Alvarez C, Garcia‐Mata R, Hauri HP, Sztul E. The p115‐interactive proteins
GM130 and giantin participate in endoplasmic reticulum‐Golgi traffic. J Biol Chem
2001;276(4):2693‐2700.
62.
Hong WJ, Lev S. Tethering the assembly of SNARE complexes. Trends in Cell
Biology 2014;24(1):35‐43.

86

63.
Waters MG, Pfeffer SR. Membrane tethering in intracellular transport. Curr
Opin Cell Biol 1999;11(4):453‐459.
64.
Yu IM, Hughson FM. Tethering Factors as Organizers of Intracellular
Vesicular Traffic. Annual Review of Cell and Developmental Biology, Vol 26
2010;26:137‐156.
65.
Brocker C, Engelbrecht‐Vandre S, Ungermann C. Multisubunit Tethering
Complexes and Their Role in Membrane Fusion. Current Biology 2010;20(21):R943‐
R952.
66.
Smith RD, Lupashin VV. Role of the conserved oligomeric Golgi (COG)
complex in protein glycosylation. Carbohydrate Research 2008;343(12):2024‐2031.
67.
Liu JL, Guo W. The exocyst complex in exocytosis and cell migration.
Protoplasma 2012;249(3):587‐597.
68.
907.

Heider MR, Munson M. Exorcising the exocyst complex. Traffic;13(7):898‐

69.
Spang A. The DSL1 Complex: The Smallest but Not the Least CATCHR. Traffic
2012;13(7):908‐913.
70.
Ren Y, Yip CK, Tripathi A, Huie D, Jeffrey PD, Walz T, Hughson FM. A
Structure‐Based Mechanism for Vesicle Capture by the Multisubunit Tethering
Complex Dsl1. Cell 2009;139(6):1119‐1129.
71.
Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nature Reviews
Molecular Cell Biology 2009;10(8):513‐525.
72.
Barr FA. Rab GTPases and membrane identity: Causal or inconsequential?
Journal of Cell Biology 2013;202(2):191‐199.
73.
Pfeffer SR. Rab GTPase regulation of membrane identity. Curr Opin Cell
Biol;25(4):414‐419.
74.
Cai H, Reinisch K, Ferro‐Novick S. Coats, tethers, Rabs, and SNAREs work
together to mediate the intracellular destination of a transport vesicle. Dev Cell
2007;12(5):671‐682.
75.
Rosing M, Ossendorf E, Rak A, Barnekow A. Giantin interacts with both the
small GTPase Rab6 and Rab1. Experimental Cell Research 2007;313(11):2318‐2325.
76.
Miller VJ, Sharma P, Kudlyk TA, Frost L, Rofe AP, Watson IJ, Duden R, Lowe M,
Lupashin VV, Ungar D. Molecular Insights into Vesicle Tethering at the Golgi by the

87

Conserved Oligomeric Golgi (COG) Complex and the Golgin TATA Element
Modulatory Factor (TMF). Journal of Biological Chemistry 2013;288(6):4229‐4240.
77.
Siniossoglou S, Pelham HRB. An effector of Ypt6p binds the SNARE Tlg1p and
mediates selective fusion of vesicles with late Golgi membranes. Embo Journal
2001;20(21):5991‐5998.
78.
Conibear E, Cleck JN, Stevens TH. Vps51p mediates the association of the
GARP (Vps52/53/54) complex with the late Golgi t‐SNARE Tlg1p. Molecular Biology
of the Cell 2003;14(4):1610‐1623.
79.
Wurmser AE, Sato TK, Emr SD. New component of the vacuolar class C‐Vps
complex couples nucleotide exchange on the Ypt7 GTPase to SNARE‐dependent
docking and fusion. Journal of Cell Biology 2000;151(3):551‐562.
80.
Seals DF, Eitzen G, Margolis N, Wickner WT, Price A. A Ypt/Rab effector
complex containing the Sec1 homolog Vps33p is required for homotypic vacuole
fusion. Proceedings of the National Academy of Sciences of the United States of
America 2000;97(17):9402‐9407.
81.
Peplowska K, Markgraf DF, Ostrowicz CW, Bange G, Ungermann C. The
CORVET tethering complex interacts with the yeast Rab5 homolog Vps21 and is
involved in endo‐lysosomal biogenesis. Developmental Cell 2007;12(5):739‐750.
82.
Brunet S, Sacher M. Are all multisubunit tethering complexes bona fide
tethers? Traffic;15(11):1282‐1287.
83.
Sacher M, Jiang Y, Barrowman J, Scarpa A, Burston J, Zhang L, Schieltz D,
Yates JR, Abeliovich H, Ferro‐Novick S. TRAPP, a highly conserved novel complex on
the cis‐Golgi that mediates vesicle docking and fusion. Embo Journal
1998;17(9):2494‐2503.
84.
Diao A, Frost L, Morohashi Y, Lowe M. Coordination of golgin tethering and
SNARE assembly ‐ GM130 binds syntaxin 5 in a p115‐regulated manner. Journal of
Biological Chemistry 2008;283(11):6957‐6967.
85.
Sivaram MVS, Saporita JA, Furgason MLM, Boettcher AJ, Munson M.
Dimerization of the exocyst protein Sec6p and its interaction with the t‐SNARE
Sec9p. Biochemistry 2005;44(16):6302‐6311.
86.
Morgera F, Sallah MR, Dubuke ML, Gandhi P, Brewer DN, Carr CM, Munson M.
Regulation of exocytosis by the exocyst subunit Sec6 and the SM protein Sec1.
Molecular Biology of the Cell 2012;23(2):337‐346.
87.
Shestakova A, Suvorova E, Pavliv O, Khaidakova G, Lupashin V. Interaction of
the conserved oligomeric Golgi complex with t‐SNARE Syntaxin5a/Sed5 enhances
88

intra‐Golgi SNARE complex stability. Journal of Cell Biology 2007;179(6):1179‐
1192.
88.
Simonsen A, Gaullier JM, D'Arrigo A, Stenmark H. The Rab5 effector EEA1
interacts directly with syntaxin‐6. Journal of Biological Chemistry
1999;274(41):28857‐28860.
89.
McBride HM, Rybin V, Murphy C, Giner A, Teasdale R, Zerial M. Oligomeric
complexes link Rab5 effectors with NSF and drive membrane fusion via interactions
between EEA1 and syntaxin 13. Cell 1999;98(3):377‐386.
90.
Mills IG, Urbe S, Clague MJ. Relationships between EEA1 binding partners and
their role in endosome fusion. Journal of Cell Science 2001;114(10):1959‐1965.
91.
Laufman O, Hong WJ, Lev S. The COG complex interacts directly with Syntaxin
6 and positively regulates endosome‐to‐TGN retrograde transport. Journal of Cell
Biology 2011;194(3):459‐472.
92.
Oka T, Ungar D, Hughson FM, Krieger M. The COG and COPI complexes
interact to control the abundance of GEARs, a subset of Golgi integral membrane
proteins. Molecular Biology of the Cell 2004;15(5):2423‐2435.
93.
Laufman O, Hong WJ, Lev S. The COG complex interacts with multiple Golgi
SNAREs and enhances fusogenic assembly of SNARE complexes. Journal of Cell
Science 2013;126(6):1506‐1516.
94.
Nakajima H, Hirata A, Ogawa Y, Yonehara T, Yoda K, Yamasaki M. A
Cytoskeleton‐Related Gene, Uso1, Is Required for Intracellular Protein‐Transport in
Saccharomyces‐Cerevisiae. Journal of Cell Biology 1991;113(2):245‐260.
95.
Barroso M, Nelson DS, Sztul E. Transcytosis‐Associated Protein (Tap)/P115
Is a General Fusion Factor Required for Binding of Vesicles to Acceptor Membranes.
Proceedings of the National Academy of Sciences of the United States of America
1995;92(2):527‐531.
96.
Sapperstein SK, Lupashin VV, Schmitt HD, Waters MG. Assembly of the ER to
Golgi SNARE complex requires Uso1p. Journal of Cell Biology 1996;132(5):755‐767.
97.
Barlowe C. Coupled ER to Golgi transport reconstituted with purified
cytosolic proteins. Journal of Cell Biology 1997;139(5):1097‐1108.
98.
Cao XC, Ballew N, Barlowe C. Initial docking of ER‐derived vesicles requires
Uso1p and Ypt1p but is independent of SNARE proteins. Embo Journal
1998;17(8):2156‐2165.

89

99.
Alvarez C, Fujita H, Hubbard A, Sztul E. ER to Golgi transport: Requirement
for p115 at a pre‐Golgi VTC stage. Journal of Cell Biology 1999;147(6):1205‐1221.
100. Brandon E, Szul T, Alvarez C, Grabski R, Benjamin R, Kawai R, Sztul E. On and
off membrane dynamics of the endoplasmic reticulum‐golgi tethering factor p115 in
vivo. Mol Biol Cell 2006;17(7):2996‐3008.
101. Sapperstein SK, Walter DM, Grosvenor AR, Heuser JE, Waters MG. P115 Is a
General Vesicular Transport Factor‐Related to the Yeast Endoplasmic‐Reticulum to
Golgi Transport Factor Uso1p. Proceedings of the National Academy of Sciences of
the United States of America 1995;92(2):522‐526.
102. Yamakawa H, Seog DH, Yoda K, Yamasaki M, Wakabayashi T. Uso1 protein is
a dimer with two globular heads and a long coiled‐coil tail. Journal of Structural
Biology 1996;116(3):356‐365.
103. Garcia‐Mata R, Gao Y, Alvarez C, Sztul ES. The membrane transport factor
p115 recycles only between homologous compartments in intact heterokaryons.
Eur J Cell Biol 2000;79(4):229‐239.
104. An Y, Chen CY, Moyer B, Rotkiewicz P, Elsliger MA, Godzik A, Wilson IA, Balch
WE. Structural and Functional Analysis of the Globular Head Domain of p115
Provides Insight into Membrane Tethering. Journal of Molecular Biology
2009;391(1):26‐41.
105. Striegl H, Roske Y, Kummel D, Heinemann U. Unusual Armadillo Fold in the
Human General Vesicular Transport Factor p115. Plos One 2009;4(2).
106. Beard M, Satoh A, Shorter J, Warren G. A cryptic Rab1‐binding site in the
p115 tethering protein (vol 280, pg 25840, 2005). Journal of Biological Chemistry
2006;281(38):28488‐28488.
107. Nelson DS, Alvarez C, Gao YS, Garcia‐Mata R, Fialkowski E, Sztul E. The
membrane transport factor TAP/p115 cycles between the Golgi and earlier
secretory compartments and contains distinct domains required for its localization
and function. Journal of Cell Biology 1998;143(2):319‐331.
108. Nakamura N, Lowe M, Levine TP, Rabouille C, Warren G. The vesicle docking
protein p115 binds GM130, a cis‐Golgi matrix protein, in a mitotically regulated
manner. Cell 1997;89(3):445‐455.
109. Shorter JG, Dirac‐Svejstrup B, Waters G, Warren G. Phosphorylation of the
vesicle tethering protein p115 by a casein kinase II‐like enzyme is required for Golgi
reassembly from isolated mitotic fragments. Molecular Biology of the Cell
2000;11:282A‐282A.

90

110. Linstedt AD, Jesch SA, Mehta A, Lee TH, Garcia‐Mata R, Nelson DS, Sztul E.
Binding relationships of membrane tethering components ‐ The giantin N terminus
and the GM130 N terminus compete for binding to the p115 C terminus. Journal of
Biological Chemistry 2000;275(14):10196‐10201.
111. Lesa GM, Seemann J, Shorter J, Vandekerckhove J, Warren G. The amino‐
terminal domain of the Golgi protein Giantin interacts directly with the vesicle‐
tethering protein p115. Journal of Biological Chemistry 2000;275(4):2831‐2836.
112. Satoh A, Warren G. In situ cleavage of the acidic domain from the p115 tether
inhibits exocytic transport. Traffic 2008;9(9):1522‐1529.
113. Puthenveedu MA, Linstedt AD. Gene replacement reveals that p115/SNARE
interactions are essential for Golgi biogenesis. Proceedings of the National Academy
of Sciences of the United States of America 2004;101(5):1253‐1256.
114. Grabski R, Balklava Z, Wyrozumska P, Szul T, Brandon E, Alvarez C, Holloway
ZG, Sztul E. Identification of a functional domain within the p115 tethering factor
that is required for Golgi ribbon assembly and membrane trafficking. Journal of Cell
Science 2012;125(8):1896‐1909.
115. Sinka R, Gillingham AK, Kondylis V, Munro S. Golgi coiled‐coil proteins
contain multiple binding sites for Rab family G proteins. Journal of Cell Biology
2008;183(4):607‐615.
116. Shorter J, Beard MB, Seemann J, Dirac‐Svejstrup AB, Warren G. Sequential
tethering of Golgins and catalysis of SNAREpin assembly by the vesicle‐tethering
protein p115. Journal of Cell Biology 2002;157(1):45‐62.
117. Garcia‐Mata R, Sztul E. The membrane‐tethering protein p115 interacts with
GBF1, an ARF guanine‐nucleotide‐exchange factor. Embo Reports 2003;4(3):320‐
325.
118. Monetta P, Slavin F, Romero N, Alvarez C. Rab1b interacts with GBF1 and
modulates both ARR dynamics and COPI association. Molecular Biology of the Cell
2007;18(7):2400‐2410.
119. Sohda M, Misumi Y, Yoshimura S, Nakamura N, Fusano T, Ogata S, Sakisaka S,
Ikehara Y. The interaction of two tethering factors, p115 and COG complex, is
required for Golgi integrity. Traffic 2007;8(3):270‐284.
120. Guo Y, Linstedt AD. Binding of the vesicle docking protein p115 to the GTPase
Rab1b regulates membrane recruitment of the COPI vesicle coat. Cell
Logist;3:e27687.

91

121. Kim S, Hill A, Warman ML, Smits P. Golgi disruption and early embryonic
lethality in mice lacking USO1. Plos One;7(11):e50530.
122. Sohda M, Misumi Y, Yoshimura S, Nakamura N, Fusano T, Sakisaka S, Ogata S,
Fujimoto J, Kiyokawa N, Ikehara Y. Depletion of vesicle‐tethering factor p115 causes
mini‐stacked Golgi fragments with delayed protein transport. Biochem Biophys Res
Commun 2005;338(2):1268‐1274.
123. Morsomme P, Riezman H. The Rab GTPase Ypt1p and tethering factors
couple protein sorting at the ER to vesicle targeting to the Golgi apparatus. Dev Cell
2002;2(3):307‐317.
124. Hu C, Ahmed M, Melia TJ, Sollner TH, Mayer T, Rothman JE. Fusion of cells by
flipped SNAREs. Science 2003;300(5626):1745‐1749.
125. Grabski R, Hay J, Sztul E. Tethering factor P115: a new model for tether‐
SNARE interactions. Bioarchitecture;2(5):175‐180.
126. Zagouras P, Rose JK. Dynamic Equilibrium between Vesicular Stomatitis‐
Virus Glycoprotein Monomers and Trimers in the Golgi and at the Cell‐Surface.
Journal of Virology 1993;67(12):7533‐7538.
127. Schwaninger R, Beckers CJM, Balch WE. Sequential Transport of Protein
between the Endoplasmic‐Reticulum and Successive Golgi Compartments in Semi‐
Intact Cells. Journal of Biological Chemistry 1991;266(20):13055‐13063.
128. Stroupe C, Collins KM, Fratti RA, Wickner W. Purification of active HOPS
complex reveals its affinities for phosphoinositides and the SNARE Vam7p. Embo
Journal 2006;25(8):1579‐1589.
129. Laage R, Ungermann C. The N‐terminal domain of the t‐SNARE Vam3p
coordinates priming and docking in yeast vacuole fusion. Molecular Biology of the
Cell 2001;12(11):3375‐3385.
130. Weimbs T, Low SH, Chapin SJ, Mostov KE, Bucher P, Hofmann K. A conserved
domain is present in different families of vesicular fusion proteins: A new
superfamily. Proceedings of the National Academy of Sciences of the United States of
America 1997;94(7):3046‐3051.
131. Tochio H, Tsui MMK, Banfield DK, Zhang MJ. An autoinhibitory mechanism
for nonsyntaxin SNARE proteins revealed by the structure of Ykt6p. Science
2001;293(5530):698‐702.
132. Martinez‐Arca S, Alberts P, Zahraoui A, Louvard D, Galli T. Role of tetanus
neurotoxin insensitive vesicle‐associated membrane protein (TI‐VAMP) in vesicular

92

transport mediating neurite outgrowth. Journal of Cell Biology 2000;149(4):889‐
899.
133. Martinez‐Arca S, Rudge R, Vacca M, Raposo G, Camonis J, Proux‐Gillardeaux
V, Daviet L, Formstecher E, Hamburger A, Filippini F, D'Esposito M, Galli T. A dual
mechanism controlling the localization and function of exocytic v‐SNAREs.
Proceedings of the National Academy of Sciences of the United States of America
2003;100(15):9011‐9016.
134. Antonin W, Dulubova I, Arac D, Pabst S, Plitzner J, Rizo J, Jahn R. The N‐
terminal domains of syntaxin 7 and vti1b form three‐helix bundles that differ in
their ability to regulate SNARE complex assembly. Journal of Biological Chemistry
2002;277(39):36449‐36456.
135. Mossessova E, Bickford LC, Goldberg J. SNARE selectivity of the COPII coat.
Cell 2003;114(4):483‐495.
136. Bentley M, Nycz DC, Joglekar A, Fertschai I, Malli R, Graier WF, Hay JC.
Vesicular Calcium Regulates Coat Retention, Fusogenicity, and Size of Pre‐Golgi
Intermediates. Molecular Biology of the Cell 2010;21(6):1033‐1046.
137. Seemann J, Jokitalo EJ, Warren G. The role of the tethering proteins p115 and
GM130 in transport through the Golgi apparatus in vivo. Molecular Biology of the
Cell 2000;11(2):635‐645.
138. Moyer BD, Allan BB, Balch WE. Rab1 interaction with a GM130 effector
complex regulates COPII vesicle cis‐Golgi tethering. Traffic 2001;2(4):268‐276.
139. Lees JA, Yip CK, Walz T, Hughson FM. Molecular organization of the COG
vesicle tethering complex. Nature Structural & Molecular Biology
2010;17(11):1292‐U1139.
140. Arasaki K, Takagi D, Furuno A, Sohda M, Misumi Y, Wakana Y, Inoue H,
Tagaya M. A new role for RINT‐1 in SNARE complex assembly at the trans‐Golgi
network in coordination with the COG complex. Molecular Biology of the Cell
2013;24(18):2907‐2917.
141. Ganley IG, Espinosa E, Pfeffer SR. A syntaxin 10‐SNARE complex
distinguishes two distinct transport routes from endosomes to the trans‐Golgi in
human cells. Journal of Cell Biology 2008;180(1):159‐172.
142. Pei JM, Ma C, Rizo J, Grishin NV. Remote Homology between Munc13 MUN
Domain and Vesicle Tethering Complexes. Journal of Molecular Biology
2009;391(3):509‐517.

93

143. Weninger K, Bowen ME, Chu S, Brunger AT. Single‐molecule studies of
SNARE complex assembly reveal parallel and antiparallel configurations. Proc Natl
Acad Sci U S A 2003;100(25):14800‐14805.

94

